¥µ¥¤¥ÈÆâ´ØÏ¢¥Ú¡¼¥¸ °äÅÁÀ­¼À´µ¤â¤¯¤¸ OMIA¡¡1¡Á100 OMIA¡¡101¡Á200 ¡üOMIA¡¡201¡Á300 OMIA¡¡301¡Á400 OMIA¡¡401¡Á500
OMIA¡¡501¡Á600 OMIA¡¡601¡Á700 OMIA¡¡701¡Á SiriuDog 001¡Á070 SiriuDog 071¡Á140 SiriuDog 141¡Á210 SiriuDog 211¡Á280
SiriuDog 281¡Á334 ʬÎàÊ̼À´µÌ¾ ¸¡ººµ¡´Ø°ìÍ÷ ¹ñÆâ°äÅÁ»Ò¸¡ººÉµ¤°ìÍ÷ ¹ñÆâ°äÅÁ»Ò¸¡ºº¸¤¼ïÊÌ °äÅÁÉÂÍѸì²òÀâ
¸¤¼ïḚ̂äÅÁÀ­¼À´µ(07ǯÅÙÅÐϿƬ¿ô½ç) 1°Ì¥À¥Ã¥¯¥¹¥Õ¥ó¥È 2°Ì¥Á¥ï¥ï 3°Ì¥×¡¼¥É¥ë 4°Ì¥è¡¼¥¯¥·¥ã¡¼¥Æ¥ê¥¢ 5°Ì¥Ý¥á¥é¥Ë¥¢¥ó


Dog Genetic disorder

2017ǯ9·î¸½ºß¤Ç707¼ï³Îǧ¤µ¤ì¤Æ¤¤¤ë¸¤¤Î°äÅÁ·Á¼Á¡¢°äÅÁÀ­¼À´µ


ºîÀ®¡¡¡¡¡¡¡¡2006ǯ12·î
ºÇ½ª¹¹¿·¡¡¡¡2017ǯ9·î

¡¦OMIAOnline Mendelian Inheritance in Animals¡¡¸¤¤Î°äÅÁ·Á¼Á
http://omia.angis.org.au/
¥ê¥¹¥È¤ÎÉÂ̾¡¦ÂåɽŪ¤Ê¾É¾õ¡¦°äÅÁ·Á¼°¡¦¤è¤¯¸¦µæ¤µ¤ì¤Æ¤¤¤ë¸¤¼ï¤äưʪ¼ï¤ÎÏÂÌõ¤È¥á¥â

¡ü¤³¤Î¥Ú¡¼¥¸¤Î¾ðÊó¤ò»ÈÍѤ¹¤ëºÝ¤Ï°ìÉôʬ¤Ç¤¢¤Ã¤Æ¤âɬ¤º¤³¤³¤ÎURL¤òÌÀµ­¤·¤Æ¤¯¤À¤µ¤¤¡£¾ðÊó¤ÎÆÈ¤êÊ⤭¤Ë¤è¤ë¥È¥é¥Ö¥ëËɻߤΤ¿¤á¤Ç¤¹¡£
¡ü¸¡º÷¤«¤éľÀܤ³¤Î¥Ú¡¼¥¸¤ËÍ褿¾ì¹ç¤Ï¤ª¼ê¿ô¤Ç¤¹¤¬°äÅÁÀ­¼À´µ¤â¤¯¤¸¤ò°ìÅÙ¤´³Îǧ´ê¤¤¤Þ¤¹¡£
.


·Á¼Á ·ì´É¡¦·ì±Õ Ǿ¿À·Ð ¶Ú¹ü³Ê¡¦·ë¹çÁÈ¿¥ ¸ÆµÛ´ï ½Û´Ä´ï ¾Ã²½´ï ¿ÕǢϩ ÀèÅ·´ñ·Á ÆâʬÈ硦Âå¼Õ ´ã¡¦¼ª¡¦É¡ ¼ðáç ÈéÉæ ¥¢¥ì¥ë¥®¡¼¡¦Ì鱅 ¤½¤Î¾


ÈÖ¹æ ¼À ´µ ̾ ¼ç ¤Ê ¾É ¾õ È÷¡¡¡¡¡¡¡¡¡¡¹Í °äÅÁ·ÁÂÖ ¸¦µæ¤µ¤ì¤Æ¤¤¤ë¸¤¼ï
201 Elbow disease
ɪ´ØÀá¼À´µ
Á°»è¤Î·ÁÂÖ°Û¾ï¤ÈÊâ¹Ô¾ã³²¡¢ìì¹Ô¤ÎÄøÅ٤Ϥµ¤Þ¤¶¤Þ ÀèÅ·À­¤Îɪ¤Î´ØÀá¤Î¼À´µ¤ÎÁí¾Î¡£¹üËì±ê¡¢´ØÀá±ê¡£Éª´ØÀá¤ÎÃÇÊÒ²½¡¢Æð¹üÍÍÉÂÊÑ¡¢Æð¹ü¤ÎµµÎö¤«¤éÆâ¦îì¾õÆÍµ¯¤ÎÎΰè¤ËÉÂÊÑ¡£·ÚÅ٤Ǥ⾭ÍèŪ¤ËÊÑ·ÁÀ­´ØÀá±ê¤Ë¿Ê¤à¥±¡¼¥¹¤¬Â¿¤¤ unknown ¿
202 Elbow dysplasia
ɪ´ØÀá·ÁÀ®ÉÔÁ´
Á°»è¤Îìì¹Ô¡¢±¿Æ°ÉÔÂÑ¡¢´ØÀá±ê ¾åÏÓ¹ü¤ÈÁ°ÏÓ¹ü¤ò¤Ä¤Ê¤°Éª´ØÀá¤Î·ÁÀ®¤Ë°Û¾ï¤¢¤ë¾õÂÖ¡ÊÉôʬŪ¤Ê´ñ·Á¡Ë unknown ¥ì¥È¥ê¥Ð¡¼¡¢¥í¥Ã¥È
203 Elbow luxation
ɪ´ØÀáæ±±
³°¤ì¤¿´ØÀá¼þ°Ï¤ÎÄˤߡ¢¼ð¤ì¡¢µ¡Ç½¾ã³²¡¢Ä̾ï¤Ïξ¦À­ ɪ¤Î´ØÀ᤬´°Á´¤Ë³°¤ì¤ë¡£Ã¦±±¡Ê¤À¤Ã¤­¤å¤¦¡¢dislocation, luxation¡Ë¤È¤Ï¡¢´ØÀá¤ò¹½À®¤¹¤ë¹üƱ»Î¤Î´ØÀáÌ̤¬Àµ¤·¤¤°ÌÃÖ´Ø·¸¤ò¼º¤Ã¤Æ¤¤¤ë¾õÂÖ¡£ ÏӼܴØÀáæ±±¡¢ÏÓÜö´ØÀáæ±±¡¢Â¿È¯À­ÀèÅ·À­¹ü³Ê°Û¾ï¤Ëȼ¤¦´ØÀá·ÁÀ®ÉÔÁ´¤Î3¤Ä¤Î¥¿¥¤¥×¤ËʬÎव¤ì¤ë¡£ÄøÅ٤ˤè¤ê´°Á´Ã¦±±¤ÈÉÔ´°Á´Ã¦±±¡Ê°¡Ã¦±±¡Ë¤ËʬÎव¤ì¤ë unknown ¥­¥ã¥Ð¥ê¥¢
204 Elbow subluxation
ɪ´ØÀᰡæ±±
³°¤ì¤¿´ØÀá¼þÊÕ¤ÎÄˤߡ¢¼ð¤ì¡¢µ¡Ç½¾ã³² ɪ¤Î´ØÀ᤬ÉÔ´°Á´¤Ë³°¤ì¤ëÉÔ´°Á´Ã¦±± unknown *
205 Elliptocytosis
ÂʱßÀÖ·ìµå¾É
Genes: SPTB
ÉÏ·ì¤Þ¤¿¤ÏÍÏ·ì¤Þ¤¿¤ÏξÊý¤È磼𡢴Î磼ð
ËìÃÁÇò¤Î°Û¾ï¤Çµ¯¤³¤êÀÖ·ìµå¤¬Âʱ߷¿¤â¤·¤¯¤ÏÍñ·¿¤Ç¡¢ÀÖ·ìµåɽÌÌÀѤ¬¸º¾¯¤¹¤ë¤¿¤áç£Â¡¤ÎÈù¾®½Û´Ä¤òÄ̲᤹¤ë¤Î¤ËɬÍפÊÀÖ·ìµå¤Î½ÀÆðÀ­¤¬Â»¤Ê¤ï¤ì¤Æ¤Îç£Â¡ÆâÍÏ·ì¡£
¿»Ø¤Ê¤É¤ÎÀèÅ·À­¹ü³Ê°Û¾ï¤¬È¼¤¦¤³¤È¤â¤¢¤ë
AD *
206 Encephalomyelopathy
ǾÀÔ¿ñ¾ã³²
Ǿ¤äÀÔ¿ñ¤Ë¤Ê¤ó¤é¤«¤ÎÉÂŪÌäÂ꤬¤¢¤ë¾õÂÖ¤ÎÁí¾Î ÀÔ¿ñ¤¬¾ã³²¤ò¼õ¤±¤ÆÀ¸¤¸¤ë±¿Æ°¾ã³²¡¦´¶³Ð¾ã³²¤ò¤ß¤ëÉÂÂÖ¡£¥ß¥¨¥í¥Ñ¥·¡¼ unknown *

Encephalomyelopathy and polyneuropathy
ǾÀÔ¿ñ¾ã³²¤È¿ȯÀ­¿À·Ð¾ã³²
µ¯Î©ÉÔǽ À¸¸å6½µ¤³¤í¤«¤éÉÔÁ´¤Þ¤Ò AR ¥Ï¥¹¥­¡¼
207 Endocardial fibroelastosis
¿´ÆâËìÀþ°ÝÃÆÀ­¾É
¿·À¸»ù´ü¤ÎÓ®ÆýÉÔÎÉ¡¢À®Ä¹ÉÔÎÉ¡¢¿´ÉÔÁ´ ¿´ÆâËì¤ÎÈî¸ü¤Ë¤è¤ê¿´Â¡Æâ¹Ð¤¬³ÈÂ礹¤ë¤¿¤á¼ý½Ìµ¡Ç½¤¬Ãø¤·¤¯Äã²¼¡¢Í½¸åÉÔÎÉ unknown ¥°¥ì¥Ç¥ó
208 Endotoxin shock
¥¨¥ó¥É¥È¥­¥·¥ó¡¦¥·¥ç¥Ã¥¯
¥·¥ç¥Ã¥¯¾õÂÖ ¶ÝÂÎÆâÆÇÁÇ¡£ÈùÀ¸Êª¤Î´¶À÷¤¬ÂÎÆâ¤Î·ì±ÕÃæ¤ËµÚ¤Ó¡¢¿¯Æþ¤·¤¿¥°¥é¥à±¢À­¶Ý¤¬²õ¤ì¡¢¥°¥é¥à±¢À­¶Ý¤ÎºÙ˦Êɤˤ¢¤ë¥¨¥ó¥É¥È¥­¥·¥ó¡ÊÆâÆÇÁǡˤȤ¤¤¦Êª¼Á¤¬Â¿Î̤ËÊü½Ð¤µ¤ì¡¢À¸ÂΤÎÌȱÖÈ¿±þ¤¬Ð¶¿Ê¤·¤¿ºÝ¤Ë¤ª¤Á¤¤¤ë¥·¥ç¥Ã¥¯¾õÂÖ unknown *
209 Entropion
´ãâÛÆâÈ¿¾É¡¢âÌÌÓÆâÈ¿¾É
µÕ¤Þ¤Ä¤² µÕ¤Þ¤Ä¤² unknown ¿¡¢Ç­¡¢ÇÏ¡¢ÍÓ
210 Epidermolysis bullosa
ɽÈé¿åá×¾É
¾®¤µ¤Ê³°½ý¤«¤é¿åË¢¤äÄÙáç¡¢ÄÞ¤ÎæÍî ÀèÅ·À­¤ª¤è¤Ó¸åÅ·À­¤ÎÈéÉæÇ´Ëì¿åá׾ɤÎÁí¾Î¡£ÈéÉæ¤ª¤è¤ÓÇ´Ëì¤Î¶ËÅÙ¤ÎÀȼåÀ­¤òÆÃħ¤È¤·¡¢Â¿È¯À­ÄÙá礬»õ·Ô¡¢¹Å¡¦Æð¸ý³¸¡¢¿°¤ÎÇ´Ëì¡¢ËËÇ´Ë줪¤è¤ÓÀå¤ÎÇØÉô¤Ë´Ñ»¡¤µ¤ì¤ë
ɽÈé¿åá׾ɤȤÏɽÈé¡Á´ðÄìËì¡Á¿¿Èé¤ÎÀÜÃå¤òô¤¦ÀÜÃ幽¤ʬ»Ò¤¬À¸¤Þ¤ì¤Ä¤­¾¯¤Ê¤¤¤«¾Ã¼º¤·¤Æ¤¤¤ë¤¿¤á¡¢Æü¾ïÀ¸³è¤ÇÈéÉæ¤Ë²Ã¤ï¤ëÎϤËÂѤ¨¤ë¤³¤È¤¬¤Ç¤­¤º¤ËɽÈ餬¿¿È餫¤éÇí¤¬¤ì¤Æ¿åáפäÈéÉæÄÙáç¤òÀ¸¤¸¤ë
unknown *
211 Epidermolysis bullosa, dystrophic
±ÉÍܾ㳲·¿É½Èé¿åá×¾É
ÈéɿɽÌ̤˿åá× Genes:COL7A1
ɽÈé¿åá׾ɤΤ¦¤Á´ðÄìËì¤È¿¿Èé¤Î´Ö¤ÇÇí¤¬¤ì¤ëÉ·¿
AR ½©Åĸ¤¡¢¥´¡¼¥ë¥Ç¥ó
212 Epidermolysis bullosa, junctionalis, LAMA3
ÀܹçÉô·¿É½Èé¿åá×¾É
À¸¤Þ¤ì¤Ä¤­´é¡¢Æ¹¡¢»Í»è¤Ë¿§ÁÇÄÀÃå¤äæÌӾɡ¢¤Ó¤é¤ó¤ä°à½ÌÀ­È©¡¢ÄÞ¥¸¥¹¥È¥í¥Õ¥£¡¼ Gene: LAMA3
°×´¶À÷À­¤ò¼¨¤¹¥¿¥¤¥×¤Ïͽ¸åÉÔÎÉ¡£¥¨¥Ê¥á¥ë¼Á·ÁÀ®ÉÔÁ´¤òȼ¤¦·Ú¾ÉÎã¤ÇºÑ¤à¥¿¥¤¥×¤â¤¢¤ë¡£ ɽÈé¿åá׾ɤΤ¦¤ÁɽÈé¤È´ðÄìËì¤Î´Ö¤ÇÇí¤¬¤ì¤Æ¿åáפ¬¤Ç¤­¤ëÉ·¿
AR G¥Ý¥¤¥ó¥¿¡¼¡¢»¨¼ï
213 Epidermolysis bullosa, simplex
ñ½ã·¿É½Èé¿åá×¾É
¼ê­¡¢´é¡¢¿°¡¢¼ª¤Î¹üδµ¯¡¢´ØÀá¾å¤ÎÈéÉæ¤Ë¿åá× 1977ǯȯ¹Ô¤Î¥¢¥á¥ê¥«½Ã°å»Õ²ñ»¨»ï¤Ë¤è¤ë¤È¿ÇÃǤµ¤ì¤¿4Ƭ¤Î¥³¥ê¡¼¤Î¤¦¤Á3Ƭ¤¬À¸¸å6¥õ·î̤Ëþ¤À¤Ã¤¿¡£¿åË¢¤Î¤Û¤«Ã¦ÌӾɡ¢¹ÈÈá¢Éâ¼ð¡¢¹ÈÈᢤӤé¤ó¡¢ÄÙáç¡¢áÐÈé¡¢°à½Ì¡¢¿§ÁÇÀ­ÊѲ½¡£³°½ý¤ËͶȯ¤µ¤ì¤Æ¿åË¢¤¬½ÐÍè¤ë¥±¡¼¥¹¤â³Îǧ¤µ¤ì¤Æ¤¤¤ë¤â¤è¤¦¡£
ɽÈé¿åá׾ɤΤ¦¤ÁɽÈ餬ÀéÀÚ¤ì¤Æ¿åáפ¬¤Ç¤­¤ëÉ·¿
unknown ¥³¥ê¡¼
214 Epidermolysis bullosa, simplex, PLEC
PLEC·¿Ã±½ãɽÈé¿åá×¾É
¿°¡¦À塦ɡ¡¦¥Ñ¥Ã¥É¡¦Ê¢Éô¤ËɽÈéÇíÎ¥á׿¾¡¦ÄÙáç Gene: PLEC
À¸¸å¤¹¤°¤Ëȯ¾É¤¬¤ß¤é¤ì¤ë¤è¤¦¤À¡£¤¢¤Þ¤ê¤Ë¤âµ¤¤ÎÆÇ¤ÇÀµ»ëº¤Æñ¤Ê¿·À¸»Ò²èÁü¥¢¥ê NCBIEpidermolysis bullosa simplex in sibling Eurasier dogs is caused by a PLEC non-sense variant.¡¡Ä̾ï°Â³Ú»¦
AR ¥æ¡¼¥é¥·¥¢
215 Epilepsy
¤Æ¤ó¤«¤ó
°Õ¼±¤ò¼º¤Ã¤ÆÈ¿±þ¤Î¤Ê¤¯¤Ê¤ë¤Æ¤ó¤«¤óȯºî ǾºÙ˦¤Î¥Í¥Ã¥È¥ï¡¼¥¯¤Ëµ¯¤­¤ë°Û¾ï¤Êȯ²Ð(¤Æ¤ó¤«¤óÊüÅÅ)¤Î¤¿¤á¤Æ¤ó¤«¤óȯºî¤òÍ褹¼À´µ¤¢¤ë¤¤¤Ï¾É¾õ AR ¿
216 Epilepsy, benign familial juvenile
ÎÉÀ­²È²À­¼ãǯÀ­¤Æ¤ó¤«¤ó
¤Æ¤ó¤«¤ó»²¾È Gene: LGI2
AR ¿
217 Epilepsy, generalized myoclonic, with photosensitivity
¸÷´¶¼õÀ­¤òȼ¤¦¥ß¥ª¥¯¥í¡¼¥Ì¥¹¤Æ¤ó¤«¤ó
¤Æ¤ó¤«¤ó»²¾È À¸¸å6½µ¤«¤é18¥õ·î¤Î´Ö¤Ëȯ¾É¤¬¤ß¤é¤ì¤Æ¤¤¤ë¤è¤¦¤À¡£¥Ò¥È¥ß¥ª¥¯¥í¡¼¥Ì¥¹â¡áò¤Î¥â¥Ç¥ëŪÌò³ä¸¦µæ¤¬´üÂÔ¤µ¤ì¤ë AR ¥í¡¼¥Ç¥·¥¢¥óRB
218 Episodic falling
ȯºîÀ­Å¾ÅÝ
¶½Ê³¤ä±¿Æ°¤ËͶȯ¤µ¤ì¤ëȯºî¡¢¶Ú¶ÛÄ¥ Gene: BCAN
1ºÐ°ÊÁ°¤Ëȯ¾É ¥¤¥®¥ê¥¹¡¡The Animal Health Trust¤Ë¤Æ¥­¥ã¥Ð¥ê¥¢¤Î°äÅÁ»Ò¸¡ºº¤¢¤ê
AR ¥­¥ã¥Ð¥ê¥¢
219 Epistaxis
É¡½Ð·ì
É¡½Ð·ì 2005ǯ¤Î¥Î¡¼¥¹¥«¥í¥é¥¤¥ÊÂç³Ø¤ÎÄ´ºº¤ÇÉ¡½Ð·ì¤Î3³ä¤Î¸¤¤¬¥Ð¥ë¥È¥Í¥é¾É(Ç­¤Ò¤Ã¤«¤­ÉÂ)´¶À÷¤Ë´ØÍ¿¤·¤Æ¤¤¤¿Êó¹ð¤¬¤¢¤ë unknown *
220 Exercise-induced collapse
±¿Æ°Í¶È¯À­µõæ
·ã¤·¤¤±¿Æ°¸åȯǮ¡¢²¼È¾¿È¤Îµõæ¡¢áÛÚ»¡£¤Þ¤ì¤Ë»àË´ Genes:DNM1
À¸¸å5¥ö·î¡Á3ºÐ¤¯¤é¤¤¤Þ¤Ç¤Ëȯ¾É
AR ¥é¥Ö¥é¥É¡¼¥ë¡¢C¥ì¥È¥ê¥Ð¡¼
221 Exfoliative cutaneous lupus erythematosus
ÇíÎ¥À­ÈéÉæ¥¨¥ê¥Æ¥Þ¥È¡¼¥Ç¥¹
Á´¿È¤ËáÐÈ顢ǿáס¢µÖ¿¾¡¢¹ÈÈá¢Ã¦ÌÓ¡¢ìì¹Ô¤È´ØÀáÄˤΤ¿¤áÇ­ÇØ¡¢ÄãÀº»Ò¡¢È¯¾ð¼þ´ü°Û¾ï¡¢¥ë¡¼¥×¥¹¿Õ±ê Á´¿ÈÀ­¥¨¥ê¥Æ¥Þ¥È¡¼¥Ç¥¹¡¢±ßÈľõ¥¨¥ê¥Æ¥Þ¥È¡¼¥Ç¥¹¡¢Â¿·ÁÀ­¹ÈÈäè¤êȯ¾ÉǯÎð¤¬Ä㤤¡£Èó¾ï¤Ë½ÅÅÙ¤ÎÈéɿɠAR GS¥Ý¥¤¥ó¥¿¡¼
222 Exophthalmos with strabismus
*´ãµåÆÍ½ÐµÚ¤Ó¼Ð»ë
»ëÎϾ㳲 °ìÈÌŪ¤Ë´ããݤ¬Àõ¤¤¤³¤È¤Ë¤è¤êÌ̤ܶ¬½Ð¤ÃÄ¥¤ë¾õÂÖ¤ò¤¤¤¦¡£Æó¼¡Åª¤Ë³ÑËì¤Ê¤É¤Î±ê¾É¤ä¥Á¥§¥ê¡¼¥¢¥¤
»²¹Í¡¨Open Veterinary Journal (2015), Vol. 5¡¡¡Ê±Ñʸpdf¡Ë
¡ØExtraocular myositis in a female puppy¡Ù
unknown ¥Ñ¥°¡¢¥·¡¼¥º¡¼¡¢¥´¥ë
223 Exostosis, multiple
¿ȯÀ­³°¹ü¼ð
¹ü¤ÎÀ®Ä¹¾ã³²¡¢¹üÊÑ·Á¡¢´ØÀá²Äư°èÀ©¸Â¡¢¾®¤Ö¤ê¡¢ÊÑ·ÁÀ­´ØÀá¾É¡¢Ëö¾¿¿À·Ð¤Ø¤Î°µÇ÷¾É¾õ Æð¹ü¤Çʤ¤ï¤ì¤¿¹ü¤ÎÎÉÀ­¼ðáç¡£°­À­¼ðáç¡¢Æð¹üÆù¼ð¤Ë¤Ê¤ê¤ä¤¹¤¤ ¥Ò¥È¤Ç¤ÏAD ¥Ü¡¼¥À¡¼¡¢¥Ç¥ó
224 Eye colour
Ìܤο§
ÀÄ¿§¤ÎÌÜ ¾®´ãµå¾É´ØÏ¢Å¾¼Ì°ø»ÒMITF¤ÎÌò³ä¤Î¸¦µæ¡¢¥À¥ë¥á¥·¥¢¥ó¤ÎÀĤ¤Ìܤȴ¶²»ÆñݤÈÇòÈäδط¸À­ unknown ¥À¥ë¥á¥·¥¢¥ó
225 Eye defects
´ã·ç»¾É
ÌܤΰìÉô¤Þ¤¿¤ÏÁ´Éô¤Îµ¡Ç½¤¬·ç»¤·¤Æ¤¤¤ë¾õÂÖ ¸¤¤Î°äÅÁÀ­ÌÖËìÊÑÀ­¤Ï¡¢¿Ê¹ÔÀ­ÌÖËì°à½Ì¾É¡¢ÌÖËì¿§ÁǾåÈ饸¥¹¥È¥í¥Õ¥£¡¼¡¢ÀèÅ·À­Äê¾ïÌëÌÕ¡¢ÃëÌդʤɤ¬¤¢¤ë unknown ¤ª¤½¤é¤¯Á´¸¤¼ï
226 Factor VII deficiency
Âè­»(¤À¤¤¤Ê¤Ê)°ø»Ò·ç˳¾É
¼ó¤«¤é¾å¤Î±ê¾É¤ä¼ð¤ì¡¢·ìƦ¾õ¤Î¤Ç¤­¤â¤Î¡¢½Ð·ì Gene: F7
°ÂÄê°ø»Ò·ç˳¾É¡£Âè­»°ø»Ò¤¬¶Ëü¤Ë·ç˳¤·¤¿¾õÂ֤ˤʤé¤Ê¤¤¸Â¤ê»à¤Ë»ê¤ë¤Û¤É½Å¾É¤Ê¥±¡¼¥¹¤ÏÈæ³ÓŪ¾¯¤Ê¤¤¡£·ì±Õ¶Å¸Ç¤Î¥×¥í¥»¥¹¤ò²Ã®¤¹¤ëÀ­¼Á¤ò»ý¤Ä¤¿¤ó¤Ñ¤¯¼Á¤Î·ç˳¤À¤¬¡¢¤¤¤Ä¤Î¤Þ¤Ë¤«²ø²æ¤ò¤·¤Æ¾¯Î̤νз줬¤¢¤ë¤¬¸¤¤¬µ¤¤Ë¤·¤Ê¤¤¤Ê¤ÉÌÀ¤é¤«¤Ê¾É¾õ¤¬½Ð¤Ë¤¯¤¯¡¢Æ°ÊªÉ±¡¤Ç¶öÁ³¤Ëȯ³Ð¤¹¤ë¤è¤¦¤Ê¥±¡¼¥¹¤¬Â¿¤¤¡£
·ì±ÕÃæ¤Î¶Å¸Ç°ø»Ò¤ÎÀèŷŪ¤Ê·ç˳(¤³¤¦¤¤¤Ã¤¿Éµ¤¤ÎÂåɽÎã¤Ï·ìͧÉÂ)¡£¶Å¸Ç°ø»Ò¤Ï12¼ïÎढ¤ê(Âè­º¤ò½ü¤¤¤ÆÂè­µ¤«¤éÂè­¾­·¤Þ¤Ç)¤½¤ÎÃæ¤Î¤É¤ì¤¬·ç˳¤·¤Æ¤¤¤ë¤«¤Ç¾É¾õ¤¬°ã¤¦
AR ¥Ó¡¼¥°¥ë¡¢¥Ð¥»¥Ã¥È¡¢¥Þ¥é¥ß¥å¡¼¥È¡¢¥¨¥¹¥­¥â¡¼
227 Factor X deficiency
ÂèX(¤À¤¤¤¸¤å¤¦)°ø»Ò·ç˳¾É
Èæ³ÓŪ½ÅÅÙ¤ÎÆâ½Ð·ì(¤¢¤¶) ¥¹¥Á¥å¥¢¡¼¥È-¥×¥é¥¦¥¢¡¼°ø»Ò·ç˳¾É¡£¾É¾õ¤Ï·ÚÅÙ¤«¤é½ÅÅ٤ޤǸÄÂκ¹¤¬¤¢¤ë¤¬°ìÈ̤˷ìͧɤÈÈæ¤Ù¤ë¤È½Ð·ì¤Ï·ÚÅ٤ǡ¢¼ã¤¤¤Û¤É¥ê¥¹¥¯¤¬¹â¤¯¿·À¸»ù»àË´¤¬¤è¤¯¤¢¤ë¡£·ÚÅÙ¡ÁÃæÄøÅÙ¤ÇÀ®¸¤¤ËÀ®Ä¹¤·¤¿¸¤¤Ï¼ê½Ñ¤Ê¤ÉÆÃ¼ì¤Ê¾ì¹ç¤ò½ü¤­¤¢¤Þ¤ê½Ð·ì¤¬µ¯¤­¤Ê¤¤¤³¤È¤â¡£·ì±ÕÃæ¤ËÄ̾︺ߤ·¤Æ¤¤¤ë·ìÀò¤ò·ÁÀ®¤¹¤ë¤¿¤ó¤Ñ¤¯¼Á¤¬·ç˳¤¹¤ë¤³¤È¤Ë¤è¤ëÆâ½Ð·ì AR¤« A¥³¥Ã¥«¡¼¡¢E¥³¥Ã¥«¡¼¡¢¥¸¥ã¥Ã¥¯¡¢Â¾¥Æ¥ê¥¢¼ï
228 Factor XI deficiency
Âè­¾­µ(¤À¤¤¤¸¤å¤¦¤¤¤Á)°ø»Ò·ç˳¾É
³°½ý¤äÈ´»õ¡¢³°²Ê¼ê½Ñ¸å¤Î½Ð·ì²á¿ Gene: F11
·ìÞù¥È¥í¥ó¥Ü¥×¥é¥¹¥Á¥óÁ°¶îʪ¼Á(PTA)·ç˳¾É¡¢¥í¡¼¥¼¥ó¥¿¡¼¥ë¾É¸õ·²¡£½Ð·ì¤Ï¤·¤Ð¤·¤ÐÃ×̿Ū¡£·ì±Õ¤Î¶Å¸Ç¤ËɬÍפʤ¿¤ó¤Ñ¤¯¼Á¤Î·ç˳¤À¤¬Æâ½Ð·ì¡¦¼«Á³½Ð·ì¤Ï¤¢¤Þ¤ê¸«¤é¤ì¤Ê¤¤
AR¤« E¥¹¥×¡¢¥±¥ê¡¼¥Ö¥ë¡¼¡¢¥Ô¥ì
229 Factor XII deficiency
Âè­¾­¶(¤À¤¤¤¸¤å¤¦¤Ë)°ø»Ò·ç˳¾É
·ìÇ¢¡¢·ìÊØ¡¢ÅÇ·ì¡¢½Ð·ì»þ´Ö±äĹ ¥Ï¡¼¥²¥Þ¥ó°ø»Ò·ç˳¾É¡£ÅǤ·¤ãʪ¤äÇ¢¤äÊØ¤Ë·ì¤¬º®¤¸¤ëÄøÅÙ¤ÇÆâ½Ð·ì¤â¾¯¤Ê¤á¡¢²ø²æ¤Î»þ¤Ï·ì¤¬»ß¤Þ¤ê¤Ë¤¯¤¤¤«¤â¤·¤ì¤Ê¤¤¡£Â¾¤Î·ì±Õ¶Å¸Ç°ø»Ò¤Î·ç˳¾É¤È¤Ï°Û¤Ê¤ê¤è¤Û¤É¤ÎÂçÎ̽зì¤Ç¤â¤Ê¤±¤ì¤Ð½Ð·ì»à¤Î¥ê¥¹¥¯¤¬Äã¤á¤À¤¬¡¢·ì±ïÆâ(²È²À­)¤Ç¥Õ¥©¥ó¥¦¥£¥ë¥Ö¥é¥ó¥ÉÉ¡¦ÍÏ·ìÀ­ÉϷ졦¥×¥ì¥«¥ê¥¯¥ì¥¤¥ó·ç˳¾É¤Îȯ¾É¤Þ¤¿¤ÏƱ»þȯÀ¸¤ÎÎ㤢¤ê AR ¥×¡¼¥É¥ë¡¢¥Ð¥»¥ó¥¸¡¼¡¢C¥·¥ã¡¼¥Ú¥¤
230 Fanconi syndrome
¥Õ¥¡¥ó¥³¥Ë¾É¸õ·²
ȯ°éÉÔÁ´¡¢Â¿°û¿Ǣ¡¢¤¯¤ëÉ¡¢¹üÆð²½¾É¡¢¶ÚÎÏÄã²¼ ¿Õ¶á°ÌÇ¢ºÙ´É¤Î¾ã³²¤Ë¤è¤ëÅüÇ¢¡¢¥ê¥ó»ÀÇ¢¡¢ÈÆ¥¢¥ß¥Î»ÀÇ¢¡¢HCO3¤ÎÁÓ¼º(Ç¢ÃæÏ³½Ð¾É)¡£
¥·¥¹¥Á¥óÇ¢¾É¤Î¾¥¦¥£¥ë¥½¥óɤäÅü¸¶É¤ò¹çÊ»¤¹¤ë¤³¤È¤â¤¢¤ë¡£¤Þ¤¿¥·¥¹¥Á¥óÇ¢¾É¤¬¸¶°ø¤Ç¥Õ¥¡¥ó¥³¥Ë¡¼¾É¸õ·²¤¬È¯À¸¤¹¤ë¾ì¹ç¤ÏÀ®Ä¹ÃÙ±ä¤ÈÌÖËì¤ËÈþõ¤Î¿§ÁÇæ¼º¤¬¤¢¤ê¿Ê¹ÔÀ­¿ÕÉÔÁ´¤ÇÁá´ü»àË´¤È¤Ê¤ê¤ä¤¹¤¤
¾ïÀ÷¿§ÂÎÀ­ ¥Ð¥»¥ó¥¸¡¼
231 Fibrodysplasia ossificans
¿Ê¹ÔÀ­¹ü²½À­Àþ°Ý°Û·ÁÀ®¾É
¥Ò¥È¤Ç¤ÏÀ¸¤Þ¤ì¤Ä¤­Ã»¤¯Â礭¤ÊÄޤȳ°È¿Êììæ¤¬¤¢¤ê³ØÆ¸´ü¤ËºÇ½é¤Î¾É¾õ¤¬¸½¤ì¤ë Á´¿È¤Î·ë¹çÁÈ¿¥¤¬½ù¡¹¤Ë¹ü²½¤¹¤ë¼À´µ¡£
»÷¤Æ¤¤¤ëɵ¤¤Ç¾É¾õ¤Î·Ú¤¤¼À´µ¤ÏÀþ°ÝÀ­¹ü°Û·ÁÀ®¡£
¥Ò¥È¤Ç¤ÏAD G¥·¥§¥Ñ¡¢Ç­
232 Focal metatarsal fistula
¶É½êÀ­ÃæÂ­¹üáñ¹¦
¸å¤í­¤Î¹Ã¤Î¾å¤ÎÉôʬ¤Ë´É¾õ¤Î·ê¤¬¤¢¤ë¾õÂÖ Ê¬Èçʪ¤¬½Ð¤Æ´¶À÷¡¢±ê¾É¡¢ÄÙáç²½¤«¤éÊâ¹Ô¤Ë»Ù¾ã¤¬½Ð¤ë¾ì¹ç¤â¤¢¤ë¤¬Ä̾ïÌ¿¤ËÊ̾õ¤Ï̵¤¤¡£
áñ¹¦(¤í¤¦¤³¤¦)¤ÏÈéÉæ¡¦Ç´Ëì¤ä¡´ï¤ÎÁÈ¿¥¤Ë¡¢±ê¾É¤Ê¤É¤Ë¤è¤Ã¤ÆÀ¸¤¸¤¿´É¾õ¤Î·ê¡£ÂÎÆâ¤ÇÏ¢Íí¤¹¤ë¤â¤Î¤È¡¢ÂÎɽ¤Ë³«¸ý¤¹¤ë¤â¤Î¤È¤¬¤¢¤ë
unknown G¥·¥§¥Ñ
233 Follicular dysplasia and interface dermatitis
Ʊ»þßÉ˦À­·ÁÀ®°Û¾ï¡¡*¥¤¥ó¥¿¡¼¥Õ¥§¥¤¥¹À­ÈéÉæ±ê
ßÉ˦À­°Û·ÁÀ®¤È³¦ÌÌÈéÉæ±ê¤¬Æ±»þ¤Ëµ¯¤³¤ë ³¦ÌÌÈéÉæ±ê¤È¤Ï¥¢¥È¥Ô¡¼¤ä¥¢¥ì¥ë¥®¡¼È¿±þ¤äSLE¤Ê¤ÉÌȱÖÈ¿±þ¤Ëµ¯°ø¤¹¤ë¿¿Èé¤ÈɽÈé¤Î¶­³¦Éôʬ¡Ê³¦Ì̡ˤαê¾ÉÀ­ÉÂÊÑ unknown ¥Ü¥¯¥µ¡¼
234 Fragile site
ÀȼåÉô
ÍÍ¡¹ À÷¿§Âξå¤ÎÀȤ¯¼å¤¤Éôʬ¡£ÀÚÃÇ¡¢Å¾ºÂ¡¢ÁýÉý¡¢·ç¼º¤Ê¤É¤¬µ¯¤³¤ê¤ä¤¹¤¤Éô°Ì unknown *
235 Fragmented coronoid process
ÃÇÊÒ²½îì¾õÆÍµ¯
Á°»è¤ÎÄˤߡ¢ìì¹Ô ɪ´ØÀá·ÁÀ®ÉÔÁ´¡£Æâ¦¤Îîì¾õÆÍµ¯¤¬ÃÇÊÒ²½¤·¤¿Éª¤Îȯ°éÉÔÁ´¤Ç¿¤¯¤Ïξ¦À­¤À¤¬°­²½ÄøÅÙ¤¬º¸±¦¤Ç°ã¤¦¤ÈÊÒ¦¤ò¤«¤Ð¤¦¤³¤È¤â unknown ¥Á¥ï¥ï¡¢¥é¥Ö¡¢¥Ð¥Ë
236 Fucosidosis, alpha
¦Á-¥Õ¥³¥·¥É¡¼¥·¥¹
Àº¿À±¿Æ°È¯Ã£ÃÙÂÚ¡¢¾®¤Ö¤ê¡¢°×´¶À÷À­¡¢Â¿È¯À­¹ü·ÁÀ®ÉÔÁ´¡¢Èï³Ñ·ì´É¼ð¡¢´ØÀá¹´½Ì¡¢¤±¤¤¤ì¤óȯºî¡¢´Îç£¼ð¡¢Æñİ¡¢¥Ø¥ë¥Ë¥¢¡¢»ëÎϾ㳲 Genes:FUCA1
¦Á-L-¥Õ¥³¥·¥À¡¼¥¼·ç»¤Ë¤è¤ëºÙ˦¥é¥¤¥½¥¾¡¼¥àÆâ¤Ø¤Î¥ª¥ê¥´ÅüÃßÀÑ¡£¥Ò¥È¤Î¾ì¹ç¤Ï2·¿¤Ëʬ¤±¤é¤ì¤ë¤³¤È¤¬Â¿¤¯¿Ê¹Ô¤ÎÁᤤ½Å¾É·¿¤ÈÈï³Ñ·ì´É¼ð¤òȼ¤¦¿Ê¹Ô¤Î´Ë¤ä¤«¤Ê·Ú¾É·¿¤¬ÃΤé¤ì¤ë¡£Èï³Ñ·ì´É¼ð¤È¤ÏɽÌ̤˲á¾ê¤Ê³Ñ²½¤òȼ¤¦·ì´É¼ð¡ÊµÖ¿¾¡Ë¤Î°ì¼ï¤Ç¾¯¤··ì¤Îº®¤¸¤Ã¤¿¤«¤µ¤Ö¤¿¤Î¤è¤¦¤Ë¤·¤«¸«¤¨¤Ê¤¤¤â¤Î¤â¤¢¤ë¡Ê°ìÈÌ»ô¤¤¼ç¤Ç¤¢¤ì¤ÐÌ¿¤¬´í¤¦¤¤Éµ¤¤Ë´Ø·¸À­¤¬¤¢¤ë¤ÈÁÛÁü¤·¤Ë¤¯¤¤¡Ë
AR *
237 Furnishings (moustache and eyebrows)
¸ý¤Ò¤²¤ÈÈýÌÓ
* Genes: RSPO2
*
¾ïÀ÷¿§ÂÎÀ­ *
238 Galactosialidosis
¥¬¥é¥¯¥È¥·¥¢¥ê¥É¡¼¥·¥¹
¹ü¤ÎÊÑ·Á¡¢´Î¡¤äç£Â¡¤Î¼ðÂç¡¢Áͷ¥إë¥Ë¥¢¡¢çÁ¥Ø¥ë¥Ë¥¢¡¢¿´ÉÔÁ´¡¢¿ÕÉÔÁ´¡¢¸ÆµÛ¾ã³²¤äÃæ¿õ¿À·Ð¾ã³²(¥ß¥ª¥¯¥í¡¼¥Ì¥¹¡¢¤±¤¤¤ì¤óȯºî) ¥é¥¤¥½¥¾¡¼¥àÀ­ÊݸîÃÁÇò¼Á/¥«¥Æ¥×¥·¥óA¡ÊPPCA¡Ë¤Î³èÀ­Äã²¼¤Ë¤è¤êÈó´Ô¸µËöü¤Ë¥·¥¢¥ë»À»Ä´ð¤ò»ý¤Ä¥ª¥ê¥´Åü¤äÅüÃÁÇò¼Á¤ª¤è¤ÓÅü»é¼Á¤¬Ê¬²ò¤µ¤ì¤º¤ËºÙ˦Æâ¤ËÃßÀѤ·¤ÆºÙ˦¤¬¾ã³²¤ò¼õ¤±¤ë¡£¥¬¥ó¥°¥ê¥ª¥·¥É¡¼¥·¥¹¤È¾É¾õ¤¬»÷¤ë¤¬¤³¤Á¤é¤Ï¤ä¤ä·Ú¤¤ unknown *
239 Gallbladder mucoceles
ÃÀǹǴ±Õǹ¼ð
²«áÕ¡ÊÇòÌܤ¬¤ï¤«¤ê¤ä¤¹¤¤¡Ë¡¢ÓÒÅÇ¡¢¿©Í߸ºÂà¡¢¸µµ¤¾ÃÄÀ¡¢ÃÀ¤Î¤¦±ê¢ªÊ¢Ëì±ê Genes: ABCB4¡¡chromosome: 7; Location: 7q21.1
´Î¡Æâ¤ËÃÀ½Á¤¬¤¦¤ÃÂÚ¤¹¤ë¡£¹çÊ»¾É¤È¤·¤Æç¹±ê¡¢¹â»é·ì¾É¡¢Éû¿ÕÈé¼Á¥¹¥Æ¥í¥¤¥É²á¾ê¡¢¹Ã¾õÁ£µ¡Ç½Äã²¼¾É¡¢ÃÁÇòϳ½ÐÀ­¿Õ¾É¡¢ÅüǢɡ¢ÃÀÀоɡ¢ÃÀǹ¤Î±¿Æ°¾ã³²¤Ê¤É¡£½é´ü¾É¾õ¤Î¤Ò¤È¤Ä¤È¤·¤Æ¿©Á°¤Î¹â¥³¥ì¥¹¥Æ¥í¡¼¥ë·ì¾É¡¢¹â¥È¥ê¥°¥ê¥»¥ê¥É·ì¾É¡¢¹â·ìÀ¶´Î¹ÚÁÇ¤Î³èÆ°¤¬°ìÈÌŪ¤È¤Ê¤ë¤¬Î×¾²Ãû¸õ¤Ï¾¯¤Ê¤¯¸«¤Ä¤±¤Ë¤¯¤¤
AR ¥·¥§¥ë¥Æ¥£
240 Gangliosidosis
¥¬¥ó¥°¥ê¥ª¥·¥É¡¼¥·¥¹
¼ãÎð´ü¤Î±¿Æ°¼ºÄ´¤«¤é»Ï¤Þ¤ê¡¢¤±¤¤¤ì¤óȯºî¡¢»ëÎÏÄã²¼(¼ºÌÀ)¡¢ÃÔÊòÍ;ɾõ¤Ê¤É¤òµ¯¤³¤·Áá´ü»àË´ ¥¬¥ó¥°¥ê¥ª¥·¥É¤Î¥é¥¤¥½¥¾¡¼¥àÃßÀÑÉ¡£»é¼ÁÂå¼Õ²óÏ©Ãæ¤ÎÆÃÄê¤Î¹ÚÁǤη绤ǻé¼Á¤Î°ì¼ï¤Ç¤¢¤ë¥¬¥ó¥°¥ê¥ª¥·¥É¤¬¿À·ÐºÙ˦¤Ê¤É¤Ë°Û¾ï¤ËÃßÀѤ¹¤ë¤³¤È¤Çµ¯¤³¤ë¡£ unknown *
241 Gangliosidosis, GM1
GM1¥¬¥ó¥°¥ê¥ª¥·¥É¡¼¥·¥¹
Ê¢¿å¤ä»Í»è¤ÎÉâ¼ð¡¢¹üÊÑ·Á¡¢¤½¤Î¾¥¬¥ó¥°¥ê¥ª¥·¥É¡¼¥·¥¹»²¾È Genes:GLB1
GM1¥¬¥ó¥°¥ê¥ª¥·¥É¦Â¥¬¥é¥¯¥È¥·¥À¡¼¥¼·ç»¾É¡¢¥é¥¤¥½¥¾¡¼¥àÃßÀÑÉÂ
AR *
242 Gangliosidosis, GM2, generic
GM2¥¬¥ó¥°¥ê¥ª¥·¥É¡¼¥·¥¹
¥¬¥ó¥°¥ê¥ª¥·¥É¡¼¥·¥¹»²¾È ¦Â¥Ø¥­¥½¥µ¥ß¥Ë¥À¡¼¥¼·ç»¾É¡¢¥é¥¤¥½¥¾¡¼¥àÃßÀÑÉ AR *
243 Gangliosidosis, GM2, GM2A deficiency
GM2¥¬¥ó¥°¥ê¥ª¥·¥É¡¼¥·¥¹GM2A·ç»¾É
¥¬¥ó¥°¥ê¥ª¥·¥É¡¼¥·¥¹»²¾È ¥é¥¤¥½¥¾¡¼¥àÃßÀÑÉ AR *
244 Gangliosidosis, GM2, type I(B variant)
¥¬¥ó¥°¥ê¥ª¥·¥É¡¼¥·¥¹GM2­µ·¿
¥¬¥ó¥°¥ê¥ª¥·¥É¡¼¥·¥¹»²¾È Gene: HEXA
¥Æ¥¤¡Ý¥µ¥Ã¥¯¥¹¡ÊTay-Sachs¡ËÉÂ
¥é¥¤¥½¥¾¡¼¥àÃßÀÑÉ¡£¥Ø¥­¥½¥µ¥ß¥Ë¥À¡¼¥¼¹ÚÁǤηçÇ¡¤Ëµ¯°ø¤¹¤ëÍÍ¡¹¤ÊÁÈ¿¥¤Ë¤ª¤±¤ëGM2¥¬¥ó¥°¥ê¥ª¥·¥É¡ÊÅü»é¼Á¤Î°ì¼ï¡Ë¤ÎÃßÀÑ
AR à¾
245 Gangliosidosis, GM2, type II(Sandhoff or variant 0)
¥¬¥ó¥°¥ê¥ª¥·¥É¡¼¥·¥¹GM2­¶·¿
¿Ê¹ÔÀ­¤Î¿À·Ð¶Úµ¡Ç½¾ã³²¡¦À®Ä¹¾ã³² Gene: HEXB
¥é¥¤¥½¥¾¡¼¥àÃßÀÑÉ¡£¥Ø¥­¥½¥µ¥ß¥Ë¥À¡¼¥¼¹ÚÁǤηçÇ¡¤Ëµ¯°ø¤¹¤ëÍÍ¡¹¤ÊÁÈ¿¥¤Ë¤ª¤±¤ëGM2¥¬¥ó¥°¥ê¥ª¥·¥É¡ÊÅü»é¼Á¤Î°ì¼ï¡Ë¤ÎÃßÀÑ¡£
AR ¥È¥¤¥×¡¼¡¢¥´¥ë¡¢Ç­
246 Gastric dilatation volvulus syndrome
°ß³ÈÄ¥¡¦Ç±Å¾¾É¸õ·²
ÓÒÅÇ¢ªÅǤ¯¤½¤Ö¤ê¤¬¤¢¤ë¤¬ÅǤ±¤Ê¤¤¢ªÊ¢ÉôËÄËþ¡¢¥·¥ç¥Ã¥¯ °ß¤Ï¿©Êª¤¬Æþ¤Ã¤Æ¤¯¤ë¤È¤â¤¾¤â¤¾¤Èư¤­°ß±Õ¤òʬÈ礷¤ÆÙøÙ¤¹¤ë¤è¤¦¤Ë¾Ã²½¤·¡¢¾Ã²½¤µ¤ì¤¿¤â¤Î¤ò½ù¡¹¤ËÍ©Ì礫¤é½½Æó»ØÄ²¤Ø¤ÈÁ÷¤ê½Ð¤¹¤¬¡¢²¿¤é¤«¤Î¸¶°ø¤ÇÍ©Ì礬³«¤«¤º°ßÆâ¤Ë¿©Êª¤¬ÄäÂÚ¤¹¤ë¤È¤½¤Î°ß±Õ¤ä¥¬¥¹¤Ê¤É¤¬Î¯¤Þ¤Ã¤Æ¤·¤Þ¤¤³ÈÄ¥¤¹¤ë¡£³ÈÄ¥¤·¤¿°ß¤ÏÂÎÆâ¤Ç·ä´Ö¤òµá¤á¤ÆÆ°¤­¤Ä¤Þ¤ê²óž¤ò¤·¤Æ¤·¤Þ¤¦¡£ ¿°ø»Ò ¿
247 Gastrointestinal stromal tumor
¾Ã²½´É´Ö¼Á¼ðáç
¼ç¤Ë¾®Ä²¤Ë¼ðáç¡¢4ºÐ¤«¤é15ºÐ¤Þ¤Ç¤ËÎ㤬¤¢¤êÊ¿¶Ñȯ¾ÉǯÎð¤Ï10ºÐ Gene: KIT
ÊÌ̾¾Ã²½´É´ÖÍÕÀ­¼ðáç¡¢¾Ã²½´É´Ö¼ÁÀ­¼ðáç¡¢°ß¾Ã²½´É´Ö¼Á¼ðáç¡¢°ßIJ´Ö¼ÁÀ­¼ðáç¡£¾Ã²½´ÉÊÉ¤Î¶ÚÆùÁؤ«¤éȯÀ¸¤¹¤ë¤¬¤ó¤Ç¼õÍÆÂη¿¥Á¥í¥·¥ó¥­¥Ê¡¼¥¼¤Î°ì¼ï¤Ç¤¢¤ëKITÃÁÇò(´´ºÙ˦°ø»Ò¼õÍÆÂÎ)¤ò¹çÀ®¤¹¤ë°äÅÁ»Ò c-kitÊѰۤˤè¤ëkit¤¿¤ó¤Ñ¤¯¼Á²á¾êȯ¸½¡£¥Ò¥È¤Îɵ¤¤È¸¶°ø¤ä·Ð²á¤¬¤Û¤ÜƱ¤¸¤Ê¤Î¤Ç¥â¥Ç¥ë¤Ë¤Ê¤êÆÀ¤ë¤¬¡¢(96ǯ¡Á06ǯ¤Î46¾ÉÎã¤Î·ë²Ì)2010ǯȯɽ¤Î¥ß¥·¥¬¥ó½£Î©Âç³Ø¤Î¸¦µæ¤Ç¤Ï´µ¸¤¤Î¼ðáç¤Î8³ä¶á¤¯¤¬¾®Ä²¤Ç2³ä¼å¤¬°ß¤Ë¤Ç¤­¤Æ¤¤¤¿(¥Ò¥È¤Ç¤Ï°ß6¡Á7³ä¾®Ä²2¡Á3³äÂçIJ¤È¿©Æ»¤¬5¥Ñ¡¼¥»¥ó¥È¤Ç50¡Á60ºÐÂå¤Ë¿¤¤)¡£
¾ïÀ÷¿§ÂÎÀ­ ¿¡¢»¨¼ï
248 Gaucher disease, type I
¥´¡¼¥·¥§É¡¡­µ·¿
¼Ð»ë¡¢À®Ä¹Ãٱ䡢¤±¤¤¤ì¤óȯºî¡¢°×¹üÀÞÀ­¡¢´Î磼𡢷쾮ÈĤθº¾¯¡¢ÉÏ·ì ¥°¥ë¥³¥»¥ì¥Ö¥í¥·¥¿¡¼¥¼Äã³èÀ­¤Ë¤è¤ë¥é¥¤¥½¥¾¡¼¥à¼À´µ¡£¥Ò¥È¤Ç¤Ï3·¿¤Ëʬ¤±¤é¤ì¤ë¾ïÀ÷¿§ÂÎÀøÀ­°äÅÁ ñ°ì°äÅÁ»Ò *
249 Generalized PRA
¿Ê¹ÔÀ­ÌÖËì°à½Ì¾É
¿Ê¹ÔÀ­¤ÎÌÖËì¤Î°à½Ì¡¢¼ºÌÀ Gene: CCDC66
*
AR ¥·¥ã¡¼¥Ú¥ó¥É¡¼¥¹
250 Genu valgum
XµÓ
À¸¸å4¥ö·îº¢¤«¤é¤ÎÇ˹ԡ¢¸å»è¤ÎÊÑ·Á¡¢ÄˤߤÎËýÀ­²½¤äÊâ¹Ôº¤Æñ¡¢ÊÑ·ÁÀ­´ØÀá±ê¡¢¸Ô´ØÀá·ÁÀ®ÉÔÁ´ ³°È¿É¨(¤¬¤¤¤Ï¤ó¤·¤Ä)¡£É¨¤¬¤¯¤Ã¤Ä¤­µ¤Ì£¤ÇµÓ¤Î»ØÀ褬³°Â¦¤ËÎ¥¤ì¤ëÊÑ·ÁŪ¤Ê¹ü³Ê¡£Ã±¤Ë¹ü³Ê¤À¤±¤¬°äÅÁ¤·¤¿¤â¤Î¡¢Â¾¤Î¼À´µ¤Î±Æ¶Á¤ò¼õ¤±¤¿¤â¤Î¡¢ÉÂŪ¤Ê¤Û¤É¤Ç¤Ï¤Ê¤¤¤â¤Î¤Ê¤É¤¬¤¢¤ë¡£
½é´ü¤Îº¢¤Ï¥ì¥ó¥È¥²¥ó¤Ç¤Î¿ÇÃÇ¤ÏÆñ¤·¤¯¡¢3DCT¤ÇÂçÂܹüðôÉô¤ÈÂçÂܹü¹ü´´Éô¤Î³ÑÅÙ(ðôÂγÑ)¡¢æú¹ü(¤±¤¤¤³¤Ä¡¦É¨¤«¤é­¼ó¤Þ¤Ç¤ÎÂÀ¤¤Êý¡¦Ê۷Ĥε㤭½ê¤¬¤¢¤ëÊý¤ÎĹ¹ü)¾åÌ̤Èɨ¤ËÀܤ¹¤ëÌ̤γÑÅ٤ʤɤ«¤é³ÎÄê¿ÇÃÇ
* ¥»¥ó¥È¥Ð¡¼¥Ê¡¼¥É¡¢Âç·¿¸¤
251 Gingival hypertrophy
»õÆùÈîÂç¾É
»þ´Ö¤ò¤«¤±¤Æ½ù¡¹¤Ë»õ·Ô¤¬¸Ç¤¯¼ð¤ì¤Æ¤¤¤­¡¢»õ·Ô¤¬»õ¤òʤ¤Ã¤Æ¤·¤Þ¤¤¼¡Âè¤Ë¤â¤Î¤¬³ú¤á¤Ê¤¯¤Ê¤ë¡£¤½¤ÎºÝÄˤߤϾ¯¤Ê¤¤¤È¹Í¤¨¤é¤ì¤Æ¤¤¤ë¤¬¼ð¤ì¤¿»õ·Ô¤Ë¿©Êª¤¬Åö¤¿¤ë¤³¤È¤Ç±ê¾É¤òµ¯¤³¤¹¾ì¹ç¤â¿¤¯¥È¥é¥Ö¥ë¤Ë¤Ê¤ê¤ä¤¹¤¤¡£¸ý¹ÐÆâ¤ÎÀ¶·é¤òÆü¾ïŪ¤ËÊݤĤ³¤È¤Ç¾­Íè¤ÎÂ礭¤Ê¼ð¤ì¤òËɤ²¤ë¥±¡¼¥¹¤¬Â¿¤¤¤è¤¦¤À¡£¹³¤±¤¤¤ì¤óÌô¤ÎÉûºîÍѤǤⵯ¤³¤ê¤ä¤¹¤¤¡£ »õÆùÁý¿£¡¢»õÆùÈî¸ü¤È¤â¡£ * *
252 Glaucoma, generic
ÎÐÆâ¾ã
»ëÌî·ç»¡¢»ëÎÏÄã²¼¡¢´ã°µ¤Î¾å¾º¤Ê¤É¤Ë¤è¤ëÄˤߡ¢ÆúºÌ¤äÌÓÍÍÂΤΰà½Ì¡¢¿å¾½ÂΤä¾Ë»ÒÂΤÎÊÑÀ­¤Ê¤ÉÍÍ¡¹¤ÊÊѲ½ ÎÐÆâ¾ã¤ÏÌÖËì¿À·ÐÀáºÙ˦¤¬»àÌǤ¹¤ë¿Ê¹ÔÀ­¤Îɵ¤ unknown ¿
253 Glaucoma, primary closed-angle
¸¶È¯À­Êĺɶù³ÑÎÐÆâ¾ã
ÎÐÆâ¾ã»²¾È * unknown ¥À¥ó¥Ç¥£
254 Glaucoma, primary open-angle
¸¶È¯À­³«Êü¶ù³ÑÎÐÆâ¾ã
ÎÐÆâ¾ã»²¾È Gene: ADAMTS10
ÀèÅ·À­ÎÐÆâ¾ã¤Ç¤ÏÁ°Ë¼¶ù³Ñ¤Î´ñ·Á¤¬ÆÃħŪ
Vetgene¤Ç¥Ó¡¼¥°¥ë°äÅÁ»Ò¸¡ºº¥¢¥ê
AR ¥Ó¡¼¥°¥ë
255 Glaucoma, primary open angle, ADAMTS10-related
ADAMTS10´ØÏ¢·¿ ¸¶È¯À­³«Êü¶ù³ÑÎÐÆâ¾ã
* Gene: ADAMTS10
*
AR ¼Æ¡¢¥·¡¼¥º¡¼¡¢¥Ó¡¼¥°¥ë¡¢N¥¨¥ë¥¯
256 Glaucoma, primary open angle, ADAMTS17-related
ADAMTS17´ØÏ¢·¿ ¸¶È¯À­³«Êü¶ù³ÑÎÐÆâ¾ã
* Gene: ADAMTS17
¸µ¤ÎÉÂ̾Glaucoma, primary open angle, due to mutations in ADAMTS17(ADAMTS17¤Ë¤ª¤±¤ëÆÍÁ³ÊѰۤ˵¯°ø¤¹¤ë¸¶È¯À­³«Êü¶ù³ÑÎÐÆâ¾ã)
AR ¥Ð¥»¥Ã¥È
257 Glioma susceptibility
¥°¥ê¥ª¡¼¥Þ´¶¼õÀ­
¿À·Ðç±¼ð(¥°¥ê¥ª¡¼¥Þ)¤ÏǾ¤ËȯÀ¸¤¹¤ë°­À­¼ðáç * unknown ¿
258 Glomerulonephritis
»åµåÂοձê
ÂνŸº¾¯¡¢¤è¤¯¿²¤ë¡¢¤¿¤ó¤Ñ¤¯Ç¢¤Ê¤É¤«¤é°­²½¤¹¤ë ¿Õ»åµåÂΤÎÁý¿£À­ÊѲ½¤Èµ¡Ç½¾ã³²¤òȼ¤¦¼À´µ·²¡£Â¾¤Î¿Õ±ê¤ÈƱ¤¸¤¯°­²½¤¹¤ë¤Þ¤Ç¤Î¾É¾õ¤¬·Ú¤¯¸«Íî¤È¤·¤¬¤Á¡£´¶À÷¾É¤ä¥á¥¹¤Î»ÒµÜÃßÇ¿¾É¤ä¥ª¥¹¤ÎÁ°Î©Á£¼À´µ¤Ê¤É¤È´ØÏ¢¤¹¤ë¤³¤È¤â¿¤¤ unknown *
259 Glomerulonephropathy
»åµåÂοվÉ
˳Ǣ¡¢·ìÇ¢¡¢¥¿¥ó¥Ñ¥¯Ç¢ Ìȱֵ¡Ç½¤Ê¤É¤¬¸¶°ø¤Çµ¯¤³¤ë»åµåÂΤαê¾É¤Ë¤è¤ë¿Õ±ê¡£»åµåÂΤȤϿÕ¡Èé¼Á¤Ë¤¢¤ë¿Õ¾®ÂΤΰìÉô¤ÇÌÓºÙ·ì´É¤Îµå¾õ¤Î¥«¥¿¥Þ¥ê¡£Ç¢¤òºî¤ëºÇ½é¤Î¹½Â¤¤Ç¸¤¤Îº¸±¦¿Õ¤Î»åµåÂοô¤ÎÊ¿¶Ñ¤Ï415,0002¡Þ130,000¡£¤³¤ÎÁ´»åµåÂΤÎ7³ä¤Îµ¡Ç½¤¬¾Ã¼º¤¹¤ë¤È¿ÕÉÔÁ´¤È¤Ê¤ë AR B¥Þ¥¹¥Á¥Õ¡¢F¥Þ¥¹¥Á¥Õ¡¢¥Ð¥Ë
260 Glossopharyngeal defect
Àå°ö·ç»
¾å¸þ¤­¤ÇÆâ¦¤Ë¥«¡¼¥ë¤·¤Æ¤¤¤ëÀè¤Î¤È¤¬¤Ã¤¿Àå À¸Â¸ÉÔǽ ARÃ×»à *
261 Gluten-sensitive enteropathy
¥°¥ë¥Æ¥ó²áÉÒÀ­Ä²¾É
Î¥Æý¸å¤ÎËýÀ­²¼Î¡¡¢¿©ÍßÉÔ¿¶¡¢¾®¤Ö¤ê ¾®Çþ¥°¥ë¥Æ¥óÃÁÇò¤Ë¤è¤ë¾®Ä²µÛ¼ýÉÔÁ´¾É¤Ê¤Î¤ÇÂнèË¡¤Ï¥°¥ë¥Æ¥ó¥Õ¥ê¡¼¤Î¿©»ö·Ñ³
¥»¥ê¥¢¥Ã¥¯É¡¢¥»¥ê¥¢¥Ã¥¯¥¹¥×¥ë¡¼
AR I¥»¥Ã¥¿¡¼
262 Glycogen storage disease I
Åü¸¶É­µ·¿
¾®¿©¡¢Äã·ìÅüȯºî(·îÎ𤬿ʤà¤È´ËϤµ¤ì¤ë)¡¢À®Ä¹Ãٱ䡢(É¡¤Ê¤É)½Ð·ì¡¢´Î¼ðÂç(Ê¢ÉôËÄËþ)¡¢¹â»é·ì¾É¡¢¹âÇ¢»À·ì¾É Gene: G6PC
¥Õ¥©¥ó¥®¡¼¥ë¥±¡£glucose-6-phosphatase°Û¾ï¤Ë¤è¤ë´Î¿Õ·¿¥°¥ê¥³¡¼¥²¥óÃßÀѾɡ£Â¿Î̤Υ°¥ê¥³¡¼¥²¥ó¤¬´Î¡¡¦¿Õ¡¤ËÃßÀÑ¡£
AR *
263 Glycogen storage disease ­¶
Åü¸¶É­¶·¿
½é´ü¤ÏÉÔ̲¤È±¿Æ°»þ¤Î¸ÆµÛº¤Æñ¤ò´Þ¤à¶ÚÎÏÄã²¼¡¢´Î¡¦¿´¼ðÂç¡¢¿´ÉÔÁ´¤ÇÁá´ü»àË´ Gene: GAA
¥Ý¥ó¥ÚÉÂ(¥Ý¥ó¥Ú¤Ïȯ¸«¤·¤¿¥ª¥é¥ó¥À¤Î°å»Õ¤Î̾)¡£»ÀÀ­¥Þ¥ë¥¿¡¼¥¼(a-¥°¥ë¥³¥·¥¿¡¼¥¼¤È¤â¸À¤¦)·ç»¤Ë¤è¤ë¥°¥ê¥³¡¼¥²¥óÃßÀѾÉ
ñ°ì°äÅÁ»Ò F¥é¥Ã¥×¥Ï¥¦¥ó¥É¡¢S¥é¥Ã¥×¥Ï¥¦¥ó¥É
264 Glycogen storage disease IIIa
Åü¸¶ÉÂIIIa·¿
´Î¼ðÂç¡¢¶ÚÎÏÄã²¼ Gene: AGL
¥³¥êÉÂ
AR *
265 Glycogen storage disease ­»
Åü¸¶É­»·¿
±¿Æ°Ãæ¤Î¶ÚÄË(¤¿¤À¤·°ìµÙ¤ß¸å¤Ë¤Ï±¿Æ°Á°¤ËÌá¤ë¤Î¤ÇµÙ·Æ¤òÆþ¤ì¤ì¤Ð³¹Ô¤Ç¤­¤ë)¡¢°×ÈèÏ«¡¢¶Ú¶¯Ä¾¡£±¿Æ°¸å¤Î¥ß¥ª¥°¥í¥Ó¥óÇ¢(Èó¾ï¤ËÇ»¤¤¿§)¡£ÍÏ·ì·¹¸þ¡¢¹â¥Ó¥ê¥ë¥Ó¥ó·ì¾É¡£·ìÀ­¥¯¥ì¥¢¥Á¥ó¥­¥Ê¡¼¥¼(CPK)¤Î¾å¾º¡£ Genes:PFKM
¿â°æÉÂ(ºÇ½é¤Ëɵ¤¤ÎÊó¹ð¤ò¤·¤¿¿â°æÂçºåÂç³ØÌ¾ÍÀ¶µ¼ø¤Ë°ø¤à)¡£¶Ú¥Û¥¹¥Û¥Õ¥ë¥¯¥È¥­¥Ê¡¼¥¼·ç»¤Ë¤è¤ë¥ß¥ª¥Ñ¥Á¡¼
AR *
266 Goitre, familial
²È²À­¹Ã¾õÁ£¼ð
¹Ã¾õÁ£¤Î³ÈÂç¡¢¼ó¤ÎÁ°¤Î¼ð¤ì ¹Ã¾õÁ£¼ð¤È¤Ï¹Ã¾õÁ£µ¡Ç½¤Î°Û¾ï¤¬´ØÏ¢¤·¤Æ¤¤¤ë¤¤¤Ê¤¤¤Ë´Ø¤ï¤é¤º¹Ã¾õÁ£¤¬³ÈÂ礵¤ì¤¿¾õÂÖ¤ÎÁí¾Î¡£

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395427/ ¹Ã¾õÁ£Âå¼Õ¤Î¸¶È¯À­ÀèÅ·°Û¾ï¤È·ì´Éȯã²áÄø¤Î·ç´Ù¤Î´ØÏ¢À­2012ǯ¤Î»¨»ïJournal of the American Animal Hospital Association¡ÊVol. 48¡Ë¤Ë¸ø³«¤µ¤ì¤¿¸¦µæ ¡ÊÀ¸¸å4¡Á5¥õ·îÎð¤Î¥ê¥Ã¥¿¡¼8Ƭ¤Î¤¦¤Á3Ƭ¤Î»Ò¸¤¤ÎÊ¢Éô»ÒµÜðôÉôÎΰè¤Ëǧ¤á¤é¤ì¤¿Î¾Â¦Èé²¼¼ðáî¤Î³Æ¼ï¸¡ºº·ë²Ì¡Ë
¹Ã¾õÁ£¥Û¥ë¥â¥ó¤Î·ìÀ¶Ç»ÅÙ¤¬´ð½àÈϰÏ̤Ëþ¤Ç¤¢¤Ã¤¿¡¢ÂçÉôʬ¤¬Á£¤ÎÎΰè¤Ë½ÅÅ٤˳ÈÄ¥¤·¤¿°Û¾ï¤ÊÌ®´É¹½Â¤¤òÍ­¤¹¤ë³ÈÂç¹Ã¾õÁ£¤ÈƱÄꤵ¤ì¤¿¡¢¹Ã¾õÁ£¼ð¤Î¸ºß¤ò½ü¤¤¤Æ¡¢¹Ã¾õÁ£µ¡Ç½Äã²¼¾É¤ÎÎ×¾²Ä§¸õ¤ò¼¨¤µ¤Ê¤«¤Ã¤¿¡¢1Ƭ¤Ïư̮´É³«Â¸¾É¤òʻȯ¡¢¤Û¤«
unknown PL¥·¡¼¥×¥É¥Ã¥°
267 Golden Retriever PRA 1
¥´¡¼¥ë¥Ç¥ó¥ì¥È¥ê¡¼¥Ð¡¼¤Î¿Ê¹ÔÀ­ÌÖËì°à½Ì¾É¡¡1·¿
¿Ê¹ÔÀ­¤ÎÌÖËì°à½Ì¤Ë¤è¤ë»ëÎϾ㳲¡¢¼ºÌÀ Gene: SLC4A3
SLC4A3·¿¡¡¥¹¥¨¡¼¥Ç¥ó¤Î¸¦µæ
AR ¥´¡¼¥ë¥Ç¥ó
268 Golden Retriever PRA 2
¥´¡¼¥ë¥Ç¥ó¥ì¥È¥ê¡¼¥Ð¡¼¤Î¿Ê¹ÔÀ­ÌÖËì°à½Ì¾É¡¡2·¿
¿Ê¹ÔÀ­¤ÎÌÖËì°à½Ì¤Ë¤è¤ë»ëÎϾ㳲¡¢¼ºÌÀ Gene: TTC8
TTC8·¿¡¡¿·µ¬ÊѰۡ¡
AR ¥´¡¼¥ë¥Ç¥ó
269 Goniodysplasia, mesodermal
ÃææõÍÕÀ­¶ö³Ñ(¤°¤¦¤«¤¯)·ÁÀ®ÉÔÁ´
* Á°Ë¼·ÁÀ®°Û¾ï¤Ë¤è¤ëȯãÎÐÆâ¾ã AR ¥Ï¥¹¥­¡¼
270 Granule cell type cerebellar hypoplasia
ðùγºÙ˦·¿¾®Ç¾Äã·ÁÀ®
Î×¾²Ãû¸õ¤¬·ÚÈù¤Ç¥Ð¥é¥ó¥¹¤¬°­¤«¤Ã¤¿¤ê¤ï¤º¤«¤Ë¤è¤í¤á¤¯ÄøÅÙ ¾®Ç¾¤Î±¿Æ°¤òÄ´À°¤¹¤ë¾ì½ê¤ÎºÙ˦¤ÎÉÔ´°Á´¤Êȯã¡¢¸Ï³é¤Ë¤è¤ë¤¬¿ÇÃǤ¬º¤Æñ¡£ ÁÈ¿¥³ØÅª¤Ë¤Ï¥×¥ë¥­¥ó¥¨ºÙ˦¤È¿ñ¼Á¤Î¹Ô¤Î´Ö¤ËðùγºÙ˦¤¬·çÇ¡¤·¤Æ¤¤¤ë¶¹¤¤¥¹¥Ú¡¼¥¹ unknown ¥Ó¡¼¥°¥ë
271 Guillain-Barr-like polyradiculoneuropathy
*¥®¥é¥ó¡¦¥Ð¥ì¡¼ÍÍ Â¿È¯¿À·Ðº¬¶Ú¾ã³²
* * unknown *
272 Haemangiosarcoma
·ì´ÉÆù¼ð
½é´ü¤«¤éÃæ´ü¤Þ¤Ç¤Ï¿©ÍßÉÔ¿¶¡¢ÓÒÅÇ¡¢²¼Î¡¤Ê¤É¤Î·Ú¤¤¾Ã²½´ï¾É¾õ¡¢Ëö´ü¤ËȽÊ̤Ǥ­¤ë¼ð¤ì¡¢ÉÏ·ì¤Ê¤É ·ì´É¤ÎÆâ¦¤Ë¤Ç¤­¤ë°­À­¼ðáç¤ÇÊ¿¶ÑŪ¤Êȯ¾ÉǯÎð¤Ï10ºÐÁ°¸å¡£¼ðáç¤ÎȯÀ¸¤Ïç£Â¡Éն᤬¿¤¯¿´Â¡¤Ëž°Ü¤¹¤ë¥±¡¼¥¹¤â¿¡£Í½¸åÉÔÎÉ unknown ¿
273 Haemolytic anaemia
ÍÏ·ìÀ­ÉÏ·ì
¿©ÍßÉÔ¿¶¡¢ÓÒÅÇ¡¢²¼Î¡¡¢Ã¦ÎÏ´¶¤Ê¤É¤«¤é¿´Çï¿ô¤¬Áý¤¨±¿Æ°µ¡Ç½¤ÎÄã²¼ ÍÏ·ì¤Ë¤è¤ëÉÏ·ì¡£¤¤¤¯¤Ä¤«¤ÎÍýͳ¤ÇÀÖ·ìµå¤¬Ç˲õ¤µ¤ì¤ë¤³¤È¤òÍÏ·ì¤È¸À¤¦¡£Ç˲õ¤µ¤ì»½ý¤ò¼õ¤±¤¿ÀÖ·ìµå¤Ïç£Â¡¡¦´Î¡¤ª¤è¤Ó¹ü¿ñ¤Ë¤ª¤±¤ëÌȱַϤˤè¤Ã¤Æ·ì±Õ¤«¤é½üµî¤µ¤ì¤ë¡£ÀÖ·ìµå¤Ï»ÀÁǤò±¿¤ÖƯ¤­¤ò»ý¤Ä¤Î¤ÇÁ´¿È¤Î³Æµ¡Ç½¤ÎÄã²¼¤Ø¤È¿Ê¤à¡£Í½¸åÉÔÎÉ¡£
4ºÐ¤«¤é5ºÐ¤Îȯ¾É¤¬Â¿¤¯¥á¥¹¸¤¤Ï¥ª¥¹¸¤¤Î4Çܤۤɥꥹ¥¯¤¬¹â¤¤¡£
°Ê²¼ÍÏ·ìÉÏ·ì¤Ç¤ÏÁóÇò¤ä²«áÕ¤âÂåɽŪ¤Ê¾É¾õ¤À¤¬¸¤¤Ç¤Ï¤ï¤«¤ê¤Ë¤¯¤¤(»õ·Ô¤äÇòÌܤÇȽÃǤǤ­¤ë¤Î¤À¤¬)¡£¥Ü¥¹¥È¥ó¥Æ¥ê¥¢¤Ç¤ÏAR
ñ°ì°äÅÁ»Ò ¥×¡¼¥É¥ë¡¢¥Ó¡¼¥°¥ë¡¢¥Ü¥¹¥Æ¥ê¡¢¥é¥Ö¾¿
274 Haemolytic anaemia, autoimmune
¼«¸ÊÌȱÖÀ­ÍÏ·ìÀ­ÉÏ·ì
ÍÏ·ì¤Ë¤è¤ëÉÏ·ì ¼«¸Ê¹³ÂΤˤè¤Ã¤Æ¼«Ê¬¤ÎÀÖ·ìµå¤òÄ̾ï¤è¤êÁ᤯Ç˲õ¤·ÍÏ·ì¤òµ¯¤³¤¹¡£Í½¸åÉÔÎÉ unknown ¿
275 Haemolytic anaemia, nonspherocytic
Èóµå¾õÀ­¼«¸ÊÌȱÖÀ­ÍÏ·ìÀ­ÉÏ·ì
磼ð PCV¤Ï30¡Á39¡ó¡ÊÀµ¾ï¡¢46¡Á56¡ó¡Ë¡¢ÀÖ·ìµå¤Ï·ÁÂÖ³ØÅª¤ËÀµ¾ï¤Ç¹ü¿ñµÛ°ú¸¡ºº¤Ë¤è¤êÀÖ·ìµå²á·ÁÀ®¤¬ÌÀ¤é¤«¤Ë¡Ê88ǯ¥ï¥·¥ó¥È¥óÂç³Ø¡Ë
°äÅÁÀ­ÍÏ·ìÀ­ÉÏ·ì¾ÉÎã¤ÎËö¾¿·ìÀÖ·ìµå¤ò´Ñ»¡¤¹¤ë¤È,ŵ·¿Åª¤Ê¾®·¿µå¾õÀÖ·ìµå¾É¤òÄ褹¤ë·²¤È,¤³¤ì¤òǧ¤á¤Ê¤¤·²¤È¤¬¤¢¤ë.Á°¼Ô¤ò°äÅÁÀ­µå¾õÀÖ·ìµå¾É,¸å¼Ô¤òÈóµå¾õÀÖ·ìµåÀ­ÍÏ·ìÀ­ÉÏ·ì¤È¤¤¤¦.¤³¤Î¸å¼Ô¤Îɰø¤Ï¼ï¡¹¤Ç¤Ï¤¢¤ë¤¬,ÂçÊ̤·¤Æ, 1)Ëì°Û¾ï¾É, 2)¥Ø¥â¥°¥í¥Ó¥ó°Û¾ï¾É, 3)²òÅü·Ï¹ÚÁǰ۾ï¾É¤¬ÃΤé¤ì¤Æ¤¤¤ë. 1)¤È¤·¤Æ¤Ï,Í­¸ýÀÖ·ìµå¾É,Í­ÛùÀÖ·ìµå¾É,ÂʱßÀÖ·ìµå¾É, 2)¤È¤·¤Æ¤Ï¥µ¥é¥»¥ß¥¢,¼ï¡¹¤Î°Û¾ï¥Ø¥â¥°¥í¥Ó¥ó¾É, 3)¤Ç¤Ï¥Ô¥ë¥Ó¥ó»À¥­¥Ê¡¼¥¼·ç˳¾É¤Ê¤É¤¬³ºÅö¤¹¤ë.¢ª°äÅÁÀ­ÂʱßÀÖ·ìµå¾É
unknown ¥Ð¥»¥ó¥¸¡¼¡¢¥Ó¡¼¥°¥ë
276 Haemolytic anaemia, primary autoimmune
¸¶È¯À­¼«¸ÊÌȱÖÀ­ÍÏ·ìÀ­ÉÏ·ì
Çö¤¤Ç´Ëì¤ÎÊø²õ(Ç´Ëì¤ÎÇö¤¤²Õ½ê¤«¤é¤Î½Ð·ì)¡¢¸µµ¤¾ÃÄÀ¡¢¿²¤Æ¤Ð¤«¤ê ¸¶È¯À­¤È¤Ï¾¤Îɵ¤¤Î·ë²Ì¤È¤·¤Æµ¯¤³¤ëɵ¤¤Ç¤Ï¤Ê¤¯¡¢¤½¤Îɵ¤¼«ÂΤ¬¸¶°ø¤È¤Ê¤ë¤â¤Î¤ò»Ø¤¹¤Î¤Ç¡¢¼«¸ÊÌȱ֤ÎÉÔ¶ñ¹ç¤¬¸¶°ø¤È¤Ê¤Ã¤ÆÍÏ·ìÀ­ÉÏ·ì¤òµ¯¤³¤¹Éµ¤
¥¹¥Æ¥í¥¤¥É·Ï¹³±ê¾ÉÌô¤Î1¤Ä¤Ç¤¢¤ë¥×¥ì¥É¥Ë¥¾¥í¥ó¤Ç·Ú²÷¤¹¤ë¤è¤¦¤À
unknown *
277 Haemolytic uremic syndrome
ÍÏ·ìÀ­Ç¢ÆÇ¾É¾É¸õ·²
Ê¢ÄË¡¢·ìÀ­²¼Î¡ÊØ¡¢ÍÏ·ì¤Ë¤è¤ëÉϷ졣ǢÆÇ¾É(BUN¹âÃÍ)¤Ë¤è¤ë°Õ¼±¾ã³² Èù¾®·ì´ÉÀ­ÍÏ·ìÀ­ÉÏ·ì¡¢µÞÀ­¿ÕÉÔÁ´¤ª¤è¤Ó·ì¾®Èĸº¾¯¾É¤òÆÃħ¤È¤¹¤ëÉÂÂÖ¡£Ê¬ÊÚ¸å¿ÕÉÔÁ´¤ä°­À­¹â·ì°µ¤Ë¹çÊ»¤¹¤ë¤³¤È¤â¤¢¤ë¡£ unknown *
278 Haemophagocytic syndrome
·ìµåìÅ¿©¾É¸õ·²
* hemophagocytic syndrome ³èÀ­²½¥Þ¥¯¥í¥Õ¥¡¡¼¥¸¤Ë¤è¤ë·ìµåìÅ¿©À­¼À´µ
¿ÇÃǤϹü¿ñÀü»É¤ÎºÙ˦¿Ç¤Î¤è¤¦¤À¡£96ǯ·ìµåìÅ¿©¾É¸õ·²¤¬·ìµå¸º¾¯¾É¤Îȯ¾É¤Ë¤ª¤¤¤Æ½ÅÍפʰø»Ò¤Ç¤¢¤êÆÀ¤ë¤³¤È¤ò¼¨º¶¤·¤¿¸¦µæ¡Ê´¶À÷¾Éȯ¾É¸¤¥¢¥ê¡Ë
unknown *
279 Haemophilia A
·ìͧÉÂA
¥ï¥¯¥Á¥óÀܼï¤Ê¤ÉÃí¼Í¸å¤Î¼ð¤ì¡¦¤·¤³¤ê¡¢½Ð·ì»þ´Ö¤Î±äĹ¡¢Ç˹ԡ¢´ØÀá±ê Genes:F8
ÂèVIII°ø»Ò·ç˳¤Ë¤è¤ë½Ð·ìÀ­¼À´µ¡£¿·À¸»ù¤ÎçÁÂӽзì²á¿¡¢ÃÇÈø¡¦¼ª¡¢ÏµÄÞÀÚ½ü»þ¡¢»õ¤ÎÀ¸¤¨ÊѤï¤ê»þ¤Î½Ð·ìÎÌÁýÂç¡¢ÄÞÀÚ¤ê»þ¤Î½Ð·ì¤Ê¤É½Å¾ÉÅ٤ˤϸÄÂκ¹¤¬·ã¤·¤¤¤¬¤Á¤ç¤Ã¤È¤·¤¿¤³¤È¤Ç¤è¤¯·ì¤¬½Ð¤ë¡£Æü¾ï¤ÎÀµ¾ï¤Êư¤­¤Ç´ØÀá¤Ë·Ñ³Ū¤Ê½Ð·ì¤¬µ¯¤³¤ê(ɪ¤äɨ¤Ê¤É)´ØÀá±ê¤Ø¤È°Ü¹Ô¤¹¤ë¡£XÀ÷¿§ÂÎÏ¢º¿ÎôÀ­°äÅÁ¤Ê¤Î¤ÇÄ̾ï¤Ï¥ª¥¹¤ËȯÀ¸¤·¥á¥¹¤Ï¥­¥ã¥ê¥¢¡¼¤À¤¬¤Þ¤ì¤Ëȯ¾É¥á¥¹¤¬¤¤¤ë
XR ¿
280 Haemophilia B
·ìͧÉÂB
·ìͧÉÂA¤È¤Û¤ÜƱ¤¸¤â¤Î¤Î¤Û¤«¡¢½Ð·ìÀ­¤Î²¼Î¡¡¢¿©ÍßÉÔ¿¶¡¢Ìµµ¤ÎÏ Genes:F9
ÂèIX°ø»Ò·ç˳¤Ë¤è¤ë½Ð·ìÀ­¼À´µ¡¢¥¯¥ê¥¹¥Þ¥¹É¡¢¥È¥í¥ó¥Ü¥×¥é¥¹¥Á¥ó¥³¥ó¥Ý¡¼¥Í¥ó¥È¡ÊPTC¡Ë·ç˳¾É¡£ÂΤΥµ¥¤¥º¤¬¾®·¿¡¦Á餻·¿¤Ë¤Ê¤ë¤Û¤ÉÇ˹Ԥ¬ÆÍÁ³¸½¤ì¤ë·¹¸þ¤¬¸«¤é¤ì¤ë
XR ¿
281 Hair, long
ĹÌÓ
Hair length¤«¤é̾¾ÎÊѹ¹¡£Á´¿È¤ÎÈïÌÓ¤ò»Ø¤¹¥³¡¼¥È¤ËÂФ·¤Æ¥Ø¥¢¡¼¤Ï°ìÉôʬ¤ÎÈïÌÓ Genes: FGF5
*
¾ïÀ÷¿§ÂÎÀ­ ¥»¥ó¥È¡¢¥ï¥¤¥Þ¡¢Â¾
282 Heart defect, congenital
ÀèÅ·À­¿´¼À´µ
Ì®Çï¤Î°Û¾ï¡¢À®Ä¹ÃÙ±ä¤Ê¤É¿´Â¡É¤ξɾõÁ´ÈÌ ÀèŷŪ(À¸¤Þ¤ì¤Ä¤­)¤Ë¿´Â¡¤Ë°Û¾ï¤¬¤¢¤ë¾ì¹ç¤ÎÁí¾Î unknown ¿
283 Heart defect, hypertrophic
ÈîÂçÀ­¿´¼À´µ
³±¡¢Â©Àڤ졢±¿Æ°ÉÔÂÑÀ­¡¢ÆÍÁ³»à¤Ê¤É¤Î¿´Â¡É¤ξɾõ ÈîÂç·¿¿´¶Ú¾É¡£Ä̾ﺸ¿´¼¼¡ÊÇÙ¤«¤éº¸¿´Ë¼¤òÄ̤ä¿¿·Á¯¤Ê·ì±Õ¤òÁ´¿È¤ØÎ϶¯¤¯Á÷¤ê½Ð¤¹Éô²°¡Ë¤Î¿´¶ÚºÙ˦¤¬ÈîÂ礷¤Æ¿´¼¼Êɤ¬¡Ê¿´Â¡¤ÎÆâ¤Ë¤â³°¤Ë¤â¡Ë¸ü¤¯¤Ê¤ê³ÈÄ¥¾ã³²¤¬µ¯¤³¤ë¡£ ³ÈÄ¥´ü¤Îû½Ì¤ÇÁ´¿È¤Ëή¤ì¤ë·ì±ÕÎ̤¬ÉÔ­¤·¤¿¤ê¿´¼¼¤«¤é¿´Ë¼¤ØµÕή¤·¤¿¤ê¤·¤ÆÇÙ¿å¼ð¤«¤é¤Î¸ÆµÛº¤Æñ¡¢¤¬À¸¤¸¤ë¤Þ¤Ç̵¾É¾õ¡Ê¤È´¶¤¸¤é¤ì¤ë¡Ë¤Ê¤³¤È¤¬Â¿¡¹¤¢¤ë¡£
ÂçÆ°Ì®ÊÛÉÕ¶á¤ÎÊÉÈî¸ü¤Ë¤è¤ëÊĺÉÀ­ÈîÂç·¿¿´¶Ú¾É¢ª¡¡¿´Î®½ÐÏ©¶¹ºõ¤Ë¤è¤ë¿´Çï½ÐÎÌÄã²¼
¿´ÀíÉô¤ÎÊÉÈî¸ü¤Ë¤è¤ëÈóÊĺÉÀ­ÈîÂç·¿¿´¶Ú¾É¢ª¡¡¿´¼¼¶ÚÈîÂç¤Ë¤è¤ëº¸¼¼³Èĥǽ¤ÎÄã²¼¤ª¤è¤ÓÉÔÀ°Ì®
unknown ¿
284 Heat tolerance
½ë¤µÂÑÀ­
* * ÉÔÌÀ ¤½¤ê¸¤
285 Height, HMGA2 associated body size variation
HMGA2´ØÏ¢¡¡Âη¿
ɵ¤¤Ç¤Ï¤Ê¤¤ 10ÈÖÀ÷¿§ÂΤÎÎΰè¤ÏºÇ¤â¹â¤¤¥ì¥Ù¥ë¤Î°äÅÁŪʬ²½¤òÍ­¤¹¤ë¡£ÂνŤȼª¤Î·Á¾õ¤ËÂ礭¤¯´ØÏ¢¤¹¤ëSNP¤òƱÄê ¿°ø»Ò ¿
286 Hemangiosarcoma
·ì´ÉÆù¼ð
* Haemangiosarcoma¤¬¤¢¤ë¤Î¤Ë¡©¡©¡©¡¡Frank Í׳Îǧ¡¡ unknown ¥´¥ë
287 Hemeralopia
ÃëÌÕ
ÌÀ¤ë¤¤¾ì½ê¤Ç¤Î»ëÎϤ¬¼å¤¤ ¿íÂÎ(¥³¡¼¥ó)ÊÑÀ­¡¢Ãæ±û¿Ê¹ÔÀ­ÌÖËì°à½Ì¾É(CPRA)¡£ÌÀ¤ë¤¤½ê¤Ë¤ª¤±¤ë»ëÎϤ¬°Å¤¤½ê¤Ë¤ª¤±¤ë»ëÎϤè¤êÎô¤ë¾É¾õ¤Ç unknown ¥×¡¼¥É¥ë¡¢¥°¥ì¥Ç¥ó
288 Hemimelia
Ⱦ»è¾É
Àµ¾ï¹½Â¤¤Î°ìÉô·ç»¤òÆÃħ¤È¤¹¤ëÀèÅ·À­´ñ·Á »Í»è¤ÎÉôʬŪ¤Þ¤¿¤Ï¤¹¤Ù¤Æ¤Î·ç»¡£Á°»è¸å»è¤È¤âµ¯¤­¤ë¡£º¸±¦¤Î»è¤Î¹ü¼«ÂΤÎŤµ¤ä¸þ¤­¤ä¹ü¤Î¿ô¤Ê¤É·Á¾õ¤ÏÂоΡ¦ÈóÂоΤɤÁ¤é¤â¸«¤é¤ì¤ë
¼ê­¤ÎÀèÅ·À­Ê¬Îöectrodactyly¡¢È¾·Â¤Þ¤¿¤Ï¼Ü¹ü¤ÎÀèÅ·À­Ê¬Àá·ç»hemimelia¡¢¤È¤¤¤¦»È¤¤¤«¤¿
unknown »³ÍÓ¡¢ÍÓ¡¢µí
289 Hemivertebrae
ȾÄǹü¾É¡¢È¾Â¦Äǹü(¤Ï¤ó¤½¤¯¤Ä¤¤¤³¤Ä)
ÄÇ´ÖÈĥإë¥Ë¥¢¤Ë»÷¤¿¾É¾õ Äǹü¤È¤ÏÇØ¹ü¤òºî¤Ã¤Æ¤¤¤ë¹ü¤Î¤³¤È¤Ç7¸Ä¤Î·ÛÄÇ¡¢13¸Ä¤Î¶»ÄÇ(Ͼ¹ü¤ÎÉôʬ)¡¢7¸Ä¤Î¹øÄÇ(ÀÔ¿ñ¤ÏÂè6¹øÄǤ«¤éÂè7¹øÄÇÉÕ¶á¤Þ¤Ç±ä¤Ó¤Æ¤¤¤ë)¡¢3¸Ä¤¬Ìþ¹ç¤·¤Æ1¤Ä¤ÎÀç¹ü¤È¤Ê¤Ã¤Æ¤¤¤ëÀçÄÇ(¤ª¿¬¤Î¥«¡¼¥Ö¤Î¤¢¤¿¤ê)¡¢20¤«¤é24¸Ä¤ÎÈøÄǤ«¤é¤Ê¤ë¡£ unknown *
290 Hepatic encephalopathy
´ÎÀ­Ç¾¾É
¿ç̲¥ê¥º¥à¤ÎµÕž¡¢¿Ì¤¨¡¢°Õ¼±¤Îº®Âù¡¦¾Ã¼º¡¢»ëÎϾ㳲¡¢Óë²¼¾ã³²¡¢¶¯Ç÷À­Êâ¹Ô ´ÎÉÔÁ´¤Ë¤è¤ëÂå¼ÕÉÔÁ´¤¬µ¯¤³¤¹Àº¿À¿À·Ð¾É¾õ unknown *
291 Hepatic encephalopathy, portosystemic
ÌçÌ®Âν۴ÄÀ­Ç¾¾É
´ÎÀ­Ç¾¾É»²¾È ¿¤¯¤ÏÌçÌ®¥·¥ã¥ó¥È¤«¤é¤Îȯ¾É¡£·ì´É¤¬´Î¡¤ò±ª²ó¤·¤Æ¤¤¤ë¤¿¤á´Î¡¤Ç²òÆÇ¤µ¤ì¤ë¤Ù¤­ÆÇÁǤ¬Á´¿È¤ò¤á¤°¤êǾ¤ËÆÇÀ­¤òµÚ¤Ü¤¹ unknown ¿
292 Hepatic fibrosis, idiopathic
ÆÃȯÀ­´ÎÀþ°Ý¾É
¿©Í߸ºÂࡢʢ¿å¡¢´ÎÀ­Ç¾¾É¡¢Áá´ü»àË´ *liver fibrosis
Ä̾ï¤Î´ÎÁÈ¿¥¤¬Èóµ¡Ç½Åª¤ÊÀþ°ÝÁÈ¿¥¤ÈÃÖ¤­´¹¤¨¤é¤ì¤Æ¤·¤Þ¤¦¡£È¯¾É¤Ï2ºÐ̤Ëþ
unknown G¥·¥§¥Ñ¡¢µí
293 Hepatitis, chronic active
ËýÀ­³èưÀ­´Î±ê
¿©ÍßÉÔ¿¶¤äÓÒÅÇ¡¢ºª¿ç¡¢¾É¾õ¤¬½Ð¤Ê¤¤¾ì¹ç¤â¿¤¤ ´ÎºÙ˦¤ÎÊÑÀ­¡¢²õ»à¡£´ÎÀ­Ç¾¾É¤Î¼çÍ׸¶°ø¤Î1¤Ä¡£¼«¸ÊÌȱ֤ˤè¤ë¤³¤È¤â¤¢¤ë¡£¿ÇÃǤϥȥé¥ó¥¹¥¢¥ß¥Ê¡¼¥¼¹âÃÍÊÑÆ°¡¢¹â¦Ã-¥°¥í¥Ö¥ê¥ó·ì¾É¤òǧ¤á¤ë¤Ê¤É¡£¥Ò¥È¤ÎC·¿´Î±ê»²¾È À­À÷¿§ÂÎÀ­¤« *
294 Hepatitis, copper-associated chronic
*Ƽ´ØÏ¢·¿ËýÀ­´Î±ê
¿©ÍßÉÔ¿¶¡¢ÓÒÅÇ¡¢´Î¹ÅÊÑ ´Î¡¤Ç¤ÎƼ¤ÎÂå¼ÕÉÔÎÉ¡£2006ǯ¤Î¥é¥Ö¥é¥É¡¼¥ë¡Ê2²È·Ï8Ƭ¡¦Èó·ì±ï6Ƭ¡Ë¤Îȯ¾É¸¤¤Î¸¦µæ¤Ç¤Ï¤À¤¤¤¿¤¤7ºÐÁ°¸å¤Ç¾É¾õ¤Ëµ¤¤Å¤¤¤¿¤È¤Î¤³¤È unknown ¥é¥Ö¡¢¥Ù¥É
295 Hepatitis, neonatal
¿·À¸»ù´Î±ê
¾®¤Ö¤ê¡¢À®Ä¹Ãٱ䡢»Ò¸¤´ü¤«¤é¤ÎÊ¢¿å¤ä²«áÕ¤äÊØ¤Î¿§¤Î°Û¾ï¡¢Â¿Ç¢¡ÊÅüÇ¢¡Ë¡¢¾®´Î À¸¸å1¥ö·î¤«¤é16¥ö·î¤Î´Ö¤Ëȯ¾É¤¹¤ë¤â¤Î¤ò¤¤¤¦¡£´ØÏ¢¡¨¡¡²È²À­ËýÀ­´Î±ê¡¢¼«¸ÊÌȱÖÀ­ËýÀ­³èưÀ­´Î±ê¡¢Hepatoportal Àþ°Ý¾É¡¢ÆÃȯÀ­´ÎÀþ°Ý¾É¡¢¼çÍפÊÌçÌ®·ÁÀ®ÉÔÁ´¡¢ ÌçÌ®Âν۴ĥ·¥ã¥ó¥È¡¢´Î·ì´É°Û·ÁÀ® unknown *
296 Hernia, diaphragmatic
²£³ÖËì¥Ø¥ë¥Ë¥¢
¸ÆµÛº¤Æñ¡¢ÓÒÅÇ¡¢¥·¥ç¥Ã¥¯¡£¿·À¸»ù¤Ç¤Ï¶»¤¬Â礭¤¯¤Õ¤¯¤é¤ßÊ¢¤Ï¤Ø¤³¤ó¤Ç¤ª¤ê¿©ÍßÉÔ¿¶¤ÎËöÁá´ü»à˴Ψ¤¬¹â¤¤(»ºÀ¼¤ò¤¢¤²¤¿¤È¤¿¤ó¤Ë¸«¤ë¸«¤ë¼å¤ë¤³¤È¤â)¡£ ÂÎÆâ¤Ç¶»¤ÈÊ¢¤òʬ¤±¡¢¸ÆµÛ¤ò¤¹¤ë¤¿¤á¤Î½ÅÍפʲ£³ÖËì¤Ë¤Ï¤â¤È¤â¤È¿ô²Õ½ê¤Ë·ê¤¬³«¤¤¤Æ¿©Æ»¤ä·ì´É¤òÄ̤·¤Æ¤¤¤ë¤¬¤½¤Î·ê¤¬Àµ¾ï¤è¤êÂ礭¤«¤Ã¤¿¤êµµÎö¤¬Æþ¤ê¤¹¤®¤Æ¤¤¤ë¤è¤¦¤Ê¾õÂÖ¤ò¤¤¤¦¡£·ÚÅ٤Ǥ¢¤ì¤Ð¤È¤¯¤Ë¤Ò¤É¤¯¤Ê¤é¤º°ìÀ¸¤ò½ª¤¨¤ë¥±¡¼¥¹¤â¿¤¤¤È¹Í¤¨¤é¤ì¤ë¡£¼ç¤Ë²£³ÖË줫¤é°ß¤Ê¤É¤¬¶»Éô¤Ë½Ð¤Æ¤·¤Þ¤¤¸ÆµÛ¤¬Ë¸¤²¤é¤ì¤ë¤³¤È¤¬Ì¿¤òÃ¥¤¦¡£
ÀèŷŪ¤Ë²£³ÖËì¥Ø¥ë¥Ë¥¢¤ò»ý¤Ã¤Æ¤¤¤Æ¡¢¤ï¤ê¤¢¤¤Àµ¾ï¤ËÀ®Ä¹¤·¤Æ¤«¤é¶»Éô¤ÎÂÇËФʤɤÇȯ¾É¤¹¤ë¥±¡¼¥¹¤â¤¢¤ë(¸åÅ·À­¤Ç¤Ï¤Ê¤¯ÃÙȯÀ­)¡£
unknown ¥´¥ë
297 Hernia, generic
¥Ø¥ë¥Ë¥¢
¾ì½ê¤Ë¤è¤Ã¤Æ¤µ¤Þ¤¶¤Þ¡£·ÚÅ٤Ǥ¢¤ì¤ÐÌ¿¤ËÊ̾ò¤¬¤Ê¤¤¤³¤È¤â¿¤¤¤¬¿Ê¹Ô¤â̵ÏÀ¤¢¤ë ¥Ø¥ë¥Ë¥¢¤È¤ÏÂÎÆâ¤Î¡´ï¤Ê¤É¤¬ËÜÍ褢¤ë¤Ù¤­Éô°Ì¤«¤éæ½Ð¤·¤¿¾õÂÖ¤ò»Ø¤¹¡£ÂÎ¹ÐÆâ¤ÎÎö·ä¤ËÌÂÆþ¤·¤¿¤â¤Î¤òÆâ¥Ø¥ë¥Ë¥¢¡¢Âιг°¤Ë°ïæ¤·¤¿¤â¤Î¤ò³°¥Ø¥ë¥Ë¥¢¤È¸Æ¤Ö¡£Ê¢Éô¤ÎÆâ¡¤Ë¿¤¯¤ß¤é¤ì¡¢Î㤨¤ÐÊ¢Êɥإë¥Ë¥¢¤Ï¡¢Ê¢ÊɤËÀ¸¤¸¤¿Îö¤±Ìܤ«¤éÊ¢Éô¤ÎÆâ¡¤¬Ê¢Ëì¤ËÊñ¤Þ¤ì¤¿¤Þ¤ÞÊ¢¹Ð³°¤Ëæ½Ð¤¹¤ë¤â¤Î¤Ç¤¢¤ë¡£(Wikipedia) * ¿
298 Hernia, hiatal
Îö¹¦¥Ø¥ë¥Ë¥¢
¿©¸å¤ÎÓÒÅÇ¡¦µÕή¡¢¸ÆµÛº¤Æñ ²¼Éô¿©Æ»³çÌó¶Ú¤Î¾ã³²¡£¿Í´Ö¤Ç¤Ï²£³ÖËì¥Ø¥ë¥Ë¥¢¡á»Ò¤É¤â(»Ò¸¤)¡¢Îö¹¦¥Ø¥ë¥Ë¥¢¡áÂç¿Í(À®¸¤)¤È¸Æ¤ó¤Ç¤¤¤ë¡£¼£ÎŤϳ°²Ê¼ê½Ñ¤ÇÎö¹¦¤ÎÊĺ¿¤È°ßÊ¢ÊɸÇÄê unknown E¥Ö¥ë
299 Hernia, inguinal
Áͷ¥إë¥Ë¥¢
ÁÍ·ÂÉô(¸Ô¤ÎÉÕ¤±º¬)¤Ëæ½Ð¤¹¤ë¥Ø¥ë¥Ë¥¢¡£¥Ø¥ë¥Ë¥¢ÎؤòÄ̤·¤ÆÊ¢¹ÐÆâ¢´ï¡¢ÆÃ¤Ë¾®Ä²¡¢Ä²´ÖËì¤Î°ìÉô¡¢ç¯æù¤Ê¤É¤¬Æþ¤ê¹þ¤ßÈé²¼¤ËÆðÀ­¡¦²Ä°ÜưÀ­¤Î¼ð¤ì¡£ Ê¢°µ¤¬¤«¤«¤ë¤È¤è¤ê½ÅÆÆ¤Ë¤Ê¤ë¤³¤È¤â unknown ¿
300 Hernia, oesophageal hiatal
¿©Æ»Îö¹¦¥Ø¥ë¥Ë¥¢
ÓÒÅÇ¡¢²áή޷¡¢µÕή * unknown C¥·¥ã¡¼¥Ú¥¤



¤³¤Î¥Ú¡¼¥¸¤ÎÀèÆ¬¤ØÌá¤ë*** 001¡Á100 *** 101¡Á200 *** 201¡Á300 *** 301¡Á400 *** 401¡Á500 *** 501¡Á600 *** 601¡Á700 *** 701¡Á